Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1050.Time spend outdoors in summer,50335,0.154270177015684,0.0439610445407265,0.0681065297158601,0.240433824315508,0.000450285595516359
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1060.Time spent outdoors in winter,48122,-0.0566809879807542,0.0487447698061776,-0.152220736800862,0.0388587608393539,0.244920129118238
PLA2G15,Phospholipase A2 group XV,Physical activities,X1070.Time spent watching television (TV),51147,0.303799059463323,0.0436502165775331,0.218244634971358,0.389353483955288,3.49967457438204e-12
PLA2G15,Phospholipase A2 group XV,Physical activities,X1080.Time spent using computer,48177,-0.188930200864065,0.0435767803439085,-0.274340690338126,-0.103519711390005,1.4610848116003e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X1090.Time spent driving,45419,-0.138156560819593,0.0476212270148152,-0.23149416576863,-0.0448189558705549,0.00372271935168406
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1160.Sleep duration,52222,0.0127939629387462,0.0398117537265761,-0.0652370743653431,0.0908250002428354,0.747939336138523
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36063,-0.004857286741671,0.0108716362704296,-0.026165693831713,0.016451120348371,0.655043085732662
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36063,0.0343783266898609,0.0119789170068693,0.0108996493563971,0.0578570040233247,0.00411751899998261
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36063,0.0300064482364886,0.0126828014695335,0.00514815735620293,0.0548647391167742,0.0180109114082734
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36063,0.0271983430129413,0.0129984456723455,0.00172138949514411,0.0526752965307384,0.036433726430561
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36063,0.0352763138570295,0.0133228078177892,0.00916361053416267,0.0613890171798964,0.00811844887697375
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36063,0.012430974672748,0.0360027152635068,-0.0581343472437253,0.0829962965892212,0.729894506583687
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36063,-0.0349025627146678,0.0419801359863315,-0.117183629247878,0.0473785038185419,0.405770563354898
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36063,-0.00125454904405862,0.0211564509517863,-0.0427211929095598,0.0402120948214426,0.952715821653168
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36063,0.015338028305466,0.0161972681698285,-0.0164086173073978,0.0470846739183298,0.343694124006656
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36063,0.0393193548289288,0.0109350314179451,0.0178866932497564,0.0607520164081011,0.000325580160989954
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36063,0.00858282320504366,0.0171796151593663,-0.0250892225073142,0.0422548689174016,0.617376098972256
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36063,0.00492812230455271,0.00816157956868058,-0.0110685736500612,0.0209248182591667,0.54598189117213
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36063,0.0101356900155884,0.0111235978638392,-0.0116665617975364,0.0319379418287132,0.362225702052996
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36063,0.0369782950505158,0.0175849998404419,0.00251169536324967,0.071444894737782,0.0355138854640597
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36063,-0.00981178573678215,0.0162704648753384,-0.0417018968924454,0.0220783254188811,0.546498581150319
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36063,0.0426819290987088,0.0201117224800427,0.00326295303782511,0.0821009051595925,0.0338503205999684
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36063,0.044870260395909,0.0195076904513401,0.00663518711128232,0.0831053336805356,0.0214682077140683
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36063,0.00259985850282872,0.0124684304113822,-0.0218382651034804,0.0270379821091379,0.834832328169687
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36063,0.0157454962659909,0.0122270314911619,-0.00821948545668649,0.0397104779886683,0.197869045567542
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36063,0.0158797571198389,0.0135611296222101,-0.0107000569396928,0.0424595711793707,0.241645816737108
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120040.Fatigue severity over the past week,36069,0.374743786888546,0.079017215006851,0.219870045475118,0.529617528301974,2.14950833993053e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120041.Waking unrefreshed severity over the past week,36072,0.214790369044324,0.0773302430831138,0.0632230926014204,0.366357645487227,0.00549032002012725
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120042.Cognitive symptoms severity over the past week,36072,0.136466335784784,0.0848713211204565,-0.0298814536113108,0.302814125180879,0.107894855936425
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120098.Mobility problems today,36074,0.38851076580618,0.0904166368909881,0.211294157499843,0.565727374112516,1.75403565899586e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120099.Self-care problems today,36074,0.359914570301934,0.135020009427199,0.095275351824625,0.624553788779243,0.00770075334116051
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120100.Problems doing usual activities,36074,0.195357359662674,0.0868772020081154,0.0250780437267674,0.36563667559858,0.0245631055327657
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120101.Pain or discomfort today,36074,0.150049647657458,0.0777908487829948,-0.00242041595721226,0.302519711272127,0.0537829025036188
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120102.Anxiety or depression today,36074,0.209208221614137,0.0988932222928036,0.0153775059202418,0.403038937308032,0.0344206946873499
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120103.Scale to indicate how health is today,36056,-0.0174182185475341,0.0035538288692055,-0.0243837231311769,-0.0104527139638913,9.72370716824093e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36058,0.289359745394449,0.0968848616537317,0.0994654165531344,0.479254074235763,0.0028298326878576
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36056,0.333796949485393,0.103151235863391,0.131620527193146,0.535973371777639,0.00121748638286479
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36062,0.225829132221549,0.0791941507727784,0.0706085967069032,0.381049667736194,0.00436208576321573
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36067,0.328297599714904,0.079707787416989,0.172070336377606,0.484524863052203,3.85020637641166e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36066,0.339994148262961,0.112854520459036,0.118799288163249,0.561189008362672,0.0025982320716167
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120109.Feeling bad about self over the last two weeks,36049,0.206689031899688,0.108639981523326,-0.0062453318860318,0.419623395685408,0.0571425910447529
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120110.Trouble concentrating over the last two weeks,36069,0.207139809870107,0.103412256890595,0.00445178636454005,0.409827833375674,0.0452081155300143
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36061,0.441795567578752,0.149725636588267,0.148333319865749,0.735257815291756,0.0031803990200694
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36028,0.120367818690743,0.209823669529846,-0.290886573587756,0.531622210969242,0.56621407247622
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33251,0.289001193049406,0.110774627494035,0.0718829231610979,0.506119462937715,0.00911216349806546
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49711,0.228658908320284,0.0962324026269984,0.0400433991713676,0.417274417469201,0.0175050486349884
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48473,0.11843714225489,0.0562439424284176,0.00819901509519129,0.228675269414588,0.0352363290731205
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1289.Cooked vegetable intake,51286,-0.239267654441019,0.0415091333690931,-0.320625555844442,-0.157909753037597,8.31010530242747e-09
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50444,-0.366597561200528,0.042901587911161,-0.450684673506404,-0.282510448894653,1.36735962513323e-17
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1309.Fresh fruit intake,51145,-0.317940998003278,0.0439298426687511,-0.40404348963403,-0.231838506372526,4.71768783900203e-13
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1319.Dried fruit intake,50150,-0.38578561984865,0.0475155173891255,-0.478916033931336,-0.292655205765964,4.94432510658367e-16
PLA2G15,Phospholipase A2 group XV,Health and medical history,X134.Number of self-reported cancers,52371,0.26074926120825,0.0853058987965878,0.0935496995669382,0.427948822849562,0.00224082705909808
PLA2G15,Phospholipase A2 group XV,Health and medical history,X135.Number of self-reported non-cancer illnesses,52372,0.392190842168921,0.0418047038732907,0.310253622577271,0.47412806176057,7.06766776229002e-21
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X136.Number of operations, self-reported",52372,0.0932712608127278,0.0395314407111263,0.0157896370189202,0.170752884606535,0.0183115795914515
PLA2G15,Phospholipase A2 group XV,Health and medical history,X137.Number of treatments or medications taken,52372,0.372769107186164,0.0406835606586844,0.293029328295142,0.452508886077185,5.46221927704731e-20
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1438.Bread intake,51821,-0.00188511256060226,0.0020496613275359,-0.00590244876257262,0.00213222364136809,0.357729150842143
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1458.Cereal intake,51157,-0.276335622919957,0.0415411967038022,-0.35775636845941,-0.194914877380505,2.95585518712492e-11
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1488.Tea intake,51495,-0.00564692203692608,0.00202072625910273,-0.00960754550476743,-0.00168629856908472,0.00520230643111154
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1498.Coffee intake,50531,-0.068435595269893,0.0413759539911298,-0.149532465092508,0.0126612745527215,0.0981429669505913
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1528.Water intake,50219,-0.0947668471487397,0.0416180696790109,-0.176338263719601,-0.0131954305778784,0.0227923603194695
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1568.Average weekly red wine intake,46715,-0.345372166449136,0.0455992215439681,-0.434746640675314,-0.255997692222959,3.79044852784602e-14
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46707,-0.158208865996558,0.0477245529686186,-0.251748989815051,-0.0646687421780658,0.000918095696526419
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1588.Average weekly beer plus cider intake,46780,0.216194361365934,0.0477506049860536,0.122603175593269,0.309785547138599,6.00436840196918e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1598.Average weekly spirits intake,46708,0.0586048240644806,0.0489746539616236,-0.0373854977003016,0.154595145829263,0.23146420907923
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1608.Average weekly fortified wine intake,46749,-0.0352005972572552,0.0878825599505893,-0.20745041476041,0.1370492202459,0.688762565154782
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1737.Childhood sunburn occasions,46100,-0.0803363376706912,0.0483491793900766,-0.175100729275241,0.0144280539338589,0.096613649987426
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1807.Father's age at death,46304,-0.00948905175840958,0.00235666100658471,-0.0141081073313156,-0.00486999618550354,5.68536028668632e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1845.Mother's age,37355,-0.0148162087924368,0.0052473673402927,-0.0251010487794105,-0.00453136880546307,0.00476021277046464
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1873.Number of full brothers,51965,0.0356470605017669,0.0396547048958294,-0.0420761610940588,0.113370282097593,0.368695764074476
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1883.Number of full sisters,51967,0.0704831711701841,0.0398987656063827,-0.00771840941832599,0.148684751758694,0.0773166463550395
PLA2G15,Phospholipase A2 group XV,Physical measures,X20015.Sitting height,52161,-0.00338017817840463,0.00265348699315849,-0.00858101268499527,0.001820656328186,0.202724635492144
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20016.Fluid intelligence score,36216,-0.21903156798402,0.0659055407036687,-0.34820642776321,-0.0898567082048291,0.000893421908598673
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20018.Prospective memory result,36569,0.388250792825929,0.0865018497663519,0.218707167283879,0.557794418367979,7.27845390036459e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36128,0.0107281756713369,0.00359612228044882,0.00367977600165723,0.0177765753410166,0.00286108321846794
PLA2G15,Phospholipase A2 group XV,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36132,0.0103354472097818,0.00360312018988035,0.0032733316376163,0.0173975627819473,0.00413606842631904
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20023.Mean time to correctly identify matches,52063,0.00699900045667289,0.00208382515474165,0.00291470315337927,0.0110832977599665,0.000784268789401113
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#1.Illnesses of father_Heart disease,48896,0.00657979567971639,0.00460921283561074,-0.00245426147808066,0.0156138528375134,0.153442189529402
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48452,-0.0129974287414881,0.0103693904695927,-0.0333214340618898,0.00732657657891371,0.210059683702095
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48410,-0.0193262671201845,0.0136708701823451,-0.0461211726775809,0.00746863843721188,0.157470920037546
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#12.Illnesses of father_Severe depression,48436,0.00926492803098071,0.0122154403873826,-0.0146773351282892,0.0332071911902507,0.448184411215127
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48457,0.00662639260830268,0.00819052340954028,-0.00942703327439627,0.0226798184910016,0.418506638865526
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#2.Illnesses of father_Stroke,48631,-0.00376492971006312,0.00591100249617535,-0.0153504946025668,0.00782063518244056,0.524173874525654
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48578,0.0119759192770878,0.00743772777973926,-0.00260202717120113,0.0265538657253768,0.107379096489608
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48471,0.0196867953019711,0.00906915911366419,0.00191124343918929,0.0374623471647529,0.0299625574141231
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48601,0.0200420416086014,0.00699122188220197,0.00633924671948558,0.0337448364977173,0.00415151588608204
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48686,0.00421432763371,0.00522804346452086,-0.00603263755675089,0.0144612928241709,0.420194536751492
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#9.Illnesses of father_Diabetes,48545,0.0241110008535781,0.0071666446086547,0.0100643774206149,0.0381576242865413,0.000768725735369518
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49699,6.34425835294133e-05,0.00548581011212711,-0.0106887452362397,0.0108156304032986,0.990772897950962
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49540,-0.000832503906871743,0.00768222820623452,-0.0158896711910914,0.0142246633773479,0.913705214507956
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49462,0.0227386659910249,0.0170609549056218,-0.0107008056239937,0.0561781376060435,0.182615362612967
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49496,0.00265420088808538,0.00911502699190488,-0.0152112520160482,0.0205196537922189,0.770909221027023
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#2.Illnesses of mother_Stroke,49642,-0.00464523415942379,0.0061662786617539,-0.0167311403364614,0.00744067201761385,0.451260896538277
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49539,0.0201720091872735,0.0103031823148145,-2.22281497628506e-05,0.0403662465243098,0.0502617468895188
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49505,0.0116215702830712,0.009377100003419,-0.00675754572363007,0.0300006862897724,0.215227399265964
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49515,0.00176930714606354,0.00786371127396718,-0.0136435669509121,0.0171821812430392,0.821984231534567
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49550,0.0201614578280219,0.00940580988588957,0.0017260704516784,0.0385968452043655,0.0320835601749339
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49748,-0.0101278834704806,0.004744333590538,-0.0194267773079351,-0.000828989633026129,0.0327943224176424
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49599,0.0150843699362831,0.0070981292700503,0.00117203656698455,0.0289967033055817,0.0335883205969765
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46628,0.00947452165924525,0.0075571068777134,-0.00533740782107302,0.0242864511395635,0.209958820374153
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46483,0.0019361918786046,0.0302852228543694,-0.0574228449159594,0.0612952286731686,0.94902516521795
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46474,0.00334251500203767,0.0304101932439264,-0.0562614637560581,0.0629464937601334,0.912478578101193
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46531,0.00268419002764661,0.00991657357634513,-0.0167522941819898,0.0221206742372831,0.78664245611561
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46491,-0.0143789978161152,0.01760033954647,-0.0488756633271964,0.020117667694966,0.413954878788731
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46527,0.00324140190695419,0.0126510454746603,-0.02155464722338,0.0280374510372884,0.797786894516466
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46497,0.0219606502058237,0.0145403461582794,-0.006538428264404,0.0504597286760513,0.130978136741362
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46502,0.0357383820775341,0.0140467866832775,0.0082066801783102,0.063270083976758,0.01095993999387
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46506,0.00826444936282695,0.0111438372011788,-0.0135774715514836,0.0301063702771375,0.4583296773821
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46524,0.0131094883819026,0.0141801374646595,-0.01468358104883,0.0409025578126352,0.355240284711392
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46694,-0.00763072115883346,0.00574967424084265,-0.018900082670885,0.00363864035321814,0.184473456525524
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46594,0.0224607475596962,0.00803330572302812,0.00671546834256113,0.0382060267768313,0.0051801733526813
PLA2G15,Phospholipase A2 group XV,Mental health,X20127.Neuroticism score,47759,0.117602632030397,0.0416272951282736,0.0360131335789803,0.199192130481813,0.00473099188086676
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36216,0.0230224507152288,0.0665791130730602,-0.107472610907969,0.153517512338427,0.729509437356032
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20161.Pack years of smoking,36878,0.0433581638292145,0.00363053966166301,0.036242306092355,0.050474021566074,1.31351226440915e-32
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36878,0.0433790919292028,0.00357814658118304,0.036365924630084,0.0503922592283215,1.52733795246976e-33
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20191.Fluid intelligence score,34271,-0.0399988099421183,0.0798051586065981,-0.196416920811051,0.116419300926814,0.616245773962032
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34272,0.0350657382150297,0.0814448320202074,-0.124566132544577,0.194697608974636,0.666814981430067
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20240.Maximum digits remembered correctly,33727,0.0304864580484981,0.0854315724831061,-0.13695942401839,0.197932340115386,0.721217046374452
PLA2G15,Phospholipase A2 group XV,Physical measures,X20255.Spirometry QC measure,45581,-0.0425314601365143,0.051189031599838,-0.142861962072197,0.0577990417991681,0.406058428341577
PLA2G15,Phospholipase A2 group XV,Eye measures,X20261.avMSE,33834,0.0033441061371058,0.00445116566133473,-0.00538017855911027,0.0120683908333219,0.452513290634792
PLA2G15,Phospholipase A2 group XV,Eye measures,X20262.Myopia diagnosis,33834,-0.119490466595978,0.101331304688708,-0.318099823785847,0.0791188905938903,0.238369829318669
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20280.Glucose-lactate,42154,0.0331263023231348,0.00259345000968722,0.0280431403041479,0.0382094643421218,3.79593051298284e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20281.Spectrometer-corrected alanine,42178,0.030039779888097,0.00274986613506614,0.0246500422633673,0.0354295175128266,1.15259246804919e-27
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35944,0.00102941102070815,0.0171385097646162,-0.0325620681179395,0.0346208901593558,0.952106130416893
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35944,0.0445842845276537,0.0376230382092885,-0.0291568703625518,0.118325439417859,0.236045448555237
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35944,-0.00289317429691294,0.0461728120832094,-0.0933918859800033,0.0876055373861774,0.950039198671031
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35944,0.0102323663703996,0.0166760349734173,-0.0224526621774983,0.0429173949182974,0.539500617216997
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35944,0.00312015258928573,0.0237492326369703,-0.0434283433791761,0.0496686485577475,0.895479027205637
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35947,0.0293764528750482,0.0320453243456307,-0.0334323828423881,0.0921852885924844,0.359321710855754
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35947,0.0142091824122641,0.0201161351838318,-0.0252184425480462,0.0536368073725744,0.479988259321985
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35947,0.0294254609411492,0.0229714803844425,-0.0155986406123581,0.0744495624946565,0.200249472156347
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35947,0.0196648570276663,0.0337110685315193,-0.0464088372941116,0.0857385513494441,0.559685493864641
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35947,0.0292284658576499,0.0376340784541844,-0.0445343279125515,0.102991259627851,0.437390941949244
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35947,0.0281840074211367,0.0242948811128846,-0.0194339595601172,0.0758019744023906,0.246053903175314
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35947,0.0745997543191905,0.0365837469318997,0.00289561033266722,0.146303898305714,0.0414707532192918
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35947,-0.00958143441437296,0.0295719582622714,-0.067542472608425,0.0483796037796791,0.745944186624474
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35950,0.0890082912374459,0.0501481143851038,-0.00928201295735753,0.187298595432249,0.0759544514147958
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35950,0.0315317541066465,0.0218289656591754,-0.0112530185853372,0.0743165267986302,0.148643411410657
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35950,-0.00144738579493586,0.0288639044218423,-0.0580206384617467,0.055125866871875,0.960008056042256
PLA2G15,Phospholipase A2 group XV,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35950,0.0899479719373758,0.0606750821900655,-0.0289751891551526,0.208871133029904,0.138262610185783
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20600.Liking for adding salt to foods,36666,0.0243442532200338,0.0678160588701068,-0.108575222165375,0.157263728605443,0.719623380139585
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20601.Liking for aniseed,36666,0.0350985201846374,0.0683833747062903,-0.0989328942396916,0.169129934608966,0.607782824689165
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20602.Liking for apple juice,36666,0.0613014743201322,0.0676964475510086,-0.0713835628798446,0.193986511520109,0.365209325490911
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20603.Liking for apples,36666,-0.0882678723276874,0.0694339844394947,-0.224358481829097,0.0478227371737223,0.203676834057194
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20604.Liking for asparagus,36666,-0.265112238892903,0.0684550197157857,-0.399284077535843,-0.130940400249963,0.000108445798420046
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20605.Liking for aubergine,36666,-0.284414456358375,0.0678288732892392,-0.417359048005284,-0.151469864711466,2.78091595945544e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20606.Liking for avocados,36666,-0.216986859070582,0.0683844421991219,-0.351020365780861,-0.0829533523603027,0.00151416363289432
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20607.Liking for bacon,36666,0.0299677017790928,0.0695194792755869,-0.106290477601058,0.166225881159243,0.666429634645255
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20608.Liking for baked or steamed fish,36666,-0.242985378860959,0.0689408325754234,-0.378109410708789,-0.107861347013129,0.000426558076899946
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20609.Liking for bananas,36666,0.0740606485105498,0.0696002467163216,-0.0623558350534405,0.21047713207454,0.287321629001874
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36666,-0.195156979002449,0.0693458596972199,-0.331074864009,-0.0592390939958981,0.00490088701600942
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20611.Liking for beef steak,36666,-0.180096212467373,0.0693291883565885,-0.315981421646287,-0.0442110032884601,0.00940220559122583
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20612.Liking for beetroot,36666,-0.121921932288208,0.0683626434641454,-0.255912713477933,0.0120688489015165,0.0745493407307682
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20613.Liking for bell pepper,36666,0.0620577574391418,0.0687800784008874,-0.0727511962265975,0.196866711104881,0.366943857151439
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20614.Liking for bicycling,36666,-0.314964507963975,0.0675505889826774,-0.447363662370023,-0.182565353557927,3.17192359441863e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20615.Liking for biscuits,36666,0.236028372766923,0.0683274823121424,0.102106507435124,0.369950238098722,0.000554421035466284
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20616.Liking for bitter foods,36666,-0.0290449863085472,0.0682934156710629,-0.16290008102383,0.104810108406736,0.67063152263462
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20617.Liking for bitter or ale,36666,-0.257442095176764,0.0689321467924924,-0.392549102890049,-0.122335087463478,0.000189222488488644
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20618.Liking for black olives,36666,-0.208107498514931,0.068752927031611,-0.342863235496889,-0.0733517615329737,0.00247865232350585
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20619.Liking for black pepper,36666,-0.0344186910097339,0.0690601111239545,-0.169776508812685,0.100939126793217,0.618224602123415
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20620.Liking for blue cheese,36666,-0.14306886841021,0.068587638985112,-0.27750064082103,-0.00863709599939064,0.0370165367284149
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20621.Liking for bolognese sauce,36666,0.00282779723255169,0.0691002414096082,-0.13260867593028,0.138264270395384,0.967358202528454
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20622.Liking for broad beans,36666,-0.122537549140174,0.0684482641463921,-0.256696146867103,0.0116210485867543,0.0734558569589867
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20623.Liking for broccoli,36666,-0.159325327396863,0.0691703252457215,-0.294899164878477,-0.0237514899152489,0.021282986830464
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20624.Liking for brown rice,36666,-0.129169996173745,0.0682148635106373,-0.262871128654595,0.00453113630710367,0.0583171668735048
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20625.Liking for brussel sprouts,36666,-0.155704992994816,0.0689694816029805,-0.290885176936658,-0.0205248090529742,0.0239977238521039
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20626.Liking for burgers (meat),36666,-0.0469999039036433,0.067639139493287,-0.179572617310486,0.0855728095031991,0.487161491267616
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20627.Liking for burn of spicy foods,36666,-0.0913685831120826,0.0687008090789458,-0.226022168906816,0.0432850026826511,0.183572670724954
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20628.Liking for butter on bread,36666,0.097171212359986,0.0688161056292685,-0.0377083546733803,0.232050779393352,0.157976296374571
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20629.Liking for butternut squash,36666,-0.27798711715293,0.0679515786627545,-0.411172211331929,-0.144802022973931,4.3377867722613e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20630.Liking for cabbage,36666,-0.049770587473843,0.0688271733620309,-0.184671847263424,0.0851306723157376,0.469624638074003
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20631.Liking for cake,36666,0.0500672168473472,0.068862616066903,-0.0849035106437826,0.185037944338477,0.467210652323347
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20632.Liking for cake icing,36666,0.176013490818828,0.0680902674087779,0.0425565666976236,0.309470414940033,0.00975524717805623
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20633.Liking for capers,36666,-0.232639757775066,0.0679049504440203,-0.365733460645346,-0.0995460549047862,0.000615685498271547
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20634.Liking for cauliflower,36666,-0.0359242995411565,0.0692235103397187,-0.171602379807005,0.0997537807246922,0.60380221785832
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20635.Liking for cereal or granola bar,36666,-0.0656529749280391,0.0676207533340452,-0.198189651462768,0.0668837016066896,0.331627330152162
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20636.Liking for cheesecake,36666,0.0983290989301268,0.068221944886172,-0.0353859130467704,0.232044110907024,0.149535458472785
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20637.Liking for cherries,36666,-0.00969898358023753,0.0696008552087391,-0.146116659789366,0.126718692628891,0.889175878608199
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20638.Liking for chicken,36666,-0.119741285175927,0.0705887180617689,-0.258095172576994,0.0186126022251402,0.0898633053977709
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20639.Liking for chilli pepper,36666,0.00146596666615997,0.0690444231536123,-0.13386110271492,0.13679303604724,0.983060934713821
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20640.Liking for chips or french fries,36666,0.136606932833936,0.0691706573385702,0.00103244445033832,0.272181421217534,0.0483106257366937
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20641.Liking for cigarette smoking,36666,0.00839175968829033,0.105595059267223,-0.198574556475468,0.215358075852048,0.93665985997223
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20642.Liking for cod,36666,-0.106958383952114,0.0703143537337309,-0.244774517270226,0.0308577493659989,0.128262494925712
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20643.Liking for coffee with sugar,36666,0.0420158398980101,0.0709194675660737,-0.0969863165314943,0.181017996327515,0.553569682019398
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20644.Liking for coffee without sugar,36666,-0.0613073623007096,0.068950425677231,-0.196450196628082,0.0738354720266632,0.373948304218336
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20645.Liking for coriander,36666,-0.140389938907967,0.0689180950048398,-0.275469405117453,-0.00531047269848101,0.0416771635777566
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20646.Liking for corn flakes,36666,0.187192225853518,0.068186004435746,0.0535476571594559,0.32083679454758,0.00605864325626222
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20647.Liking for cream,36666,0.12421904407059,0.0685075539805007,-0.0100557617311914,0.258493849872371,0.0698355914452731
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20648.Liking for croissant,36666,-0.00142074950169023,0.0678233415752854,-0.13435449898925,0.131512999985869,0.983287818256988
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20649.Liking for cucumber,36666,0.0874975812976603,0.0682749076456918,-0.0463212376878957,0.221316400283216,0.200038079829398
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20650.Liking for curry,36666,-0.0486346818303577,0.0698160474057319,-0.185474134745592,0.0882047710848769,0.486065871123022
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20651.Liking for dairy products,36666,0.138375704175502,0.0693884569164044,0.00237432861934891,0.274377079731654,0.0461618872959876
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20652.Liking for dark chocolate,36666,-0.0599607663968668,0.0690542572403278,-0.195307110587909,0.0753855777941757,0.385248417104365
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20653.Liking for diet fizzy drinks,36666,0.175035243011832,0.0692489589442521,0.0393072834810981,0.310763202542566,0.0115027265276022
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20654.Liking for dried fruit,36666,-0.182206434283883,0.0682744781305663,-0.316024411419792,-0.0483884571479727,0.00762901959170757
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20655.Liking for eggs,36666,-0.0223924037144823,0.0701521030020465,-0.159890525598493,0.115105718169529,0.749584727016922
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20656.Liking for exercising alone,36666,-0.289314004198903,0.0677450584893263,-0.422094318837982,-0.156533689559823,1.97160297371534e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20657.Liking for exercising with others,36666,-0.285379879617207,0.0673936166994241,-0.417471368348078,-0.153288390886335,2.31581827137331e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20658.Liking for extra virgin olive oil,36666,-0.173418327901319,0.069087182010961,-0.308829204642802,-0.0380074511598351,0.0120878557574621
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20659.Liking for fatty foods,36666,0.00149881076190938,0.0676827751147662,-0.131159428463032,0.134157049986851,0.982333125138463
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20660.Liking for fresh tomatoes,36666,-0.108244320368279,0.0710706892029556,-0.247542871206072,0.0310542304695141,0.127785065359904
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20661.Liking for fried chicken,36666,-0.031632339603464,0.0681622040119687,-0.165230259466923,0.101965580259995,0.642606920604367
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20662.Liking for fried or battered fish,36666,0.0787318997174378,0.06841238906858,-0.055356382856979,0.212820182291855,0.249831100370706
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20663.Liking for fruit,36666,0.00322542532510499,0.0724176437015272,-0.138713156329888,0.145164006980098,0.964475694132285
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20664.Liking for garlic,36666,-0.0910084762274003,0.0692492374321392,-0.226736981594393,0.0447200291395925,0.188810839419569
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20665.Liking for gherkins,36666,-0.125212480246569,0.0678115034364447,-0.258123026982001,0.00769806648886281,0.0648594157075216
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20666.Liking for globe artichoke,36666,-0.236595529287745,0.0679354711944507,-0.369749052828868,-0.103442005746621,0.000499110605362892
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20667.Liking for goat's cheese,36666,-0.278741730852296,0.0682897822055722,-0.412589703975217,-0.144893757729374,4.51298740431892e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20668.Liking for going to a cafe,36666,-0.167544304931118,0.0689137843778296,-0.302615322311664,-0.0324732875505726,0.0150698943648591
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20669.Liking for going to the gym,36666,-0.395832192917828,0.0677352389606623,-0.528593261280726,-0.26307112455493,5.30040239491531e-09
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20670.Liking for going to the pub,36666,-0.164083701716373,0.0677733484723577,-0.296919464722194,-0.0312479387105515,0.0154970469127776
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20671.Liking for grapefruit,36666,-0.00647741236901796,0.0689635074032775,-0.141645886879442,0.128691062141406,0.925170897953703
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20672.Liking for green olives,36666,-0.244628493093043,0.0689226521465085,-0.3797168913002,-0.109540094885886,0.000388429292703412
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20673.Liking for haddock,36666,-0.252615800845002,0.0703371148603481,-0.390476545971285,-0.11475505571872,0.000330737386308869
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20674.Liking for ham,36666,0.0947353009146544,0.0688249057298096,-0.0401615143157723,0.229632116145081,0.168714945834965
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20675.Liking for hard cheese,36666,0.121726015834216,0.069705214461713,-0.014896204510741,0.258348236179174,0.0807974439266573
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20676.Liking for herring,36666,-0.258535519829691,0.0680574771064733,-0.391928174958379,-0.125142864701004,0.000146478533127686
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20677.Liking for honey,36666,-0.141319174898328,0.06845404159661,-0.275489096427683,-0.00714925336897193,0.0390080691559128
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20678.Liking for horseradish or wasabi,36666,-0.132920395672932,0.0685033206158268,-0.267186904079952,0.00134611273408902,0.0523720514457056
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20679.Liking for ice cream,36666,0.0817495812586148,0.0691609937542867,-0.0538059664997871,0.217305129017017,0.237233203072193
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20680.Liking for jam,36666,0.0884275676043108,0.0688573194188158,-0.0465327784565682,0.22338791366519,0.19910384061857
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20681.Liking for kiwi fruit,36666,0.00155451527080528,0.0684340447051433,-0.132576212351276,0.135685242892886,0.98187775418436
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20682.Liking for lager,36666,-0.0396344740600092,0.0681030727555418,-0.173116496660871,0.0938475485408527,0.560597941253784
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20683.Liking for lamb,36666,-0.239443504129244,0.0694110791221874,-0.375489219208732,-0.103397789049757,0.000564201976663408
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20684.Liking for lemons,36666,-0.00625896807059332,0.0688609943307134,-0.141226516958792,0.128708580817605,0.927580036701732
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20685.Liking for lentils or beans,36666,-0.0466683118811632,0.068331416389578,-0.180597888004736,0.0872612642424097,0.494645395635891
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20686.Liking for liver,36666,-0.167458501909774,0.068024794220101,-0.300787098581172,-0.0341299052383764,0.0138477644855033
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20687.Liking for mackerel,36666,-0.339147757806957,0.0690144266395062,-0.474416034020389,-0.203879481593525,9.09237979685143e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20688.Liking for marzipan,36666,0.102282795963401,0.0683739628756583,-0.0317301712728893,0.236295763199691,0.134710555418064
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20689.Liking for mayonnaise,36666,-0.0999373945430918,0.0689077122094078,-0.234996510473531,0.0351217213873475,0.147011623172286
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20690.Liking for melon,36666,0.0484024844388677,0.0691450635154615,-0.0871218400514369,0.183926808929172,0.483939025777895
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20691.Liking for milk chocolate,36666,0.0140199098609873,0.0687328717016566,-0.12069651867426,0.148736338396234,0.838376795868687
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20692.Liking for mushrooms,36666,-0.0694854866957048,0.0698276118016382,-0.206347605826916,0.0673766324355062,0.319717304318379
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20694.Liking for orange juice,36666,0.0698694643180072,0.0692390263253622,-0.0658390272797027,0.205577955915717,0.312954468550183
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20695.Liking for oranges,36666,0.0102297594539561,0.0693726762729483,-0.125740686041023,0.146200204948935,0.882771904581249
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20696.Liking for pasta,36666,-0.0480794460878731,0.0695300409493657,-0.18435832634863,0.0881994341728837,0.489276519941595
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20697.Liking for pears,36666,0.148351718712531,0.0682810651962588,0.014520830927864,0.282182606497199,0.0298347683681312
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20698.Liking for pizza,36666,0.0901878772461006,0.0681568321736654,-0.0433995138142836,0.223775268306485,0.185792977394979
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20699.Liking for plain yogurt,36666,-0.1528635535851,0.0681593332592461,-0.286455846773223,-0.0192712603969779,0.0249407684536706
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20700.Liking for plums,36666,0.0382138503697147,0.0687281661019998,-0.0964933551902048,0.172921055929634,0.578216447279687
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20701.Liking for pollock,36666,-0.161938718203892,0.0677701571499008,-0.294768226217698,-0.0291092101900869,0.0168928710300345
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20702.Liking for pork chop,36666,-0.0809195519176649,0.0684142342443223,-0.215011451036537,0.0531723472012068,0.236927982494411
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20703.Liking for porridge,36666,-0.153219311159082,0.0688027612009644,-0.288072723112972,-0.0183658992051916,0.0259791135681633
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20704.Liking for potato crisps,36666,0.0662661905669246,0.0682805138922505,-0.0675636166618865,0.200095997795736,0.33182680930198
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20705.Liking for potatoes,36666,0.176734092144572,0.069846062600035,0.0398358094485032,0.31363237484064,0.0114141765905447
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20706.Liking for prawns,36666,-0.179905522047079,0.0695772448059534,-0.316276921866748,-0.0435341222274107,0.00973568431125744
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20707.Liking for raw carrots,36666,-0.135059065620819,0.0687139946887627,-0.269738495210794,-0.00037963603084426,0.0493878151280797
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20708.Liking for red meat,36666,-0.157098508787466,0.0691132740218226,-0.292560525870238,-0.0216364917046935,0.0230488718634305
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20709.Liking for red wine,36666,-0.347028028351577,0.0697021748132337,-0.483644290985515,-0.210411765717639,6.53323368651858e-07
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36666,0.17417918646455,0.0690950427293836,0.0387529027149583,0.309605470214142,0.011725862688396
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20711.Liking for roast chicken,36666,-0.116491653942094,0.0710201510194219,-0.255691149940161,0.0227078420559731,0.100989742342733
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20712.Liking for salad dressing,36666,0.0253512931116431,0.0687172202615716,-0.109334458601037,0.160037044824323,0.712195571746311
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20713.Liking for salad leaves,36666,-0.196070658419209,0.0685821533355384,-0.330491678956864,-0.0616496378815539,0.0042618163775396
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20714.Liking for salami,36666,-0.0681476259354392,0.0680190939388818,-0.201465050055648,0.0651697981847692,0.316426982067641
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20715.Liking for salmon,36666,-0.184961261612642,0.0701116289199139,-0.322380054295673,-0.047542468929611,0.00835330443900845
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20716.Liking for salty foods,36666,0.0683497616559296,0.0681983273164004,-0.0653189598842153,0.202018483196074,0.316267207304996
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20717.Liking for salty pretzels,36666,0.0126948119640575,0.0678590015919176,-0.120308831156101,0.145698455084216,0.85160550852829
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20718.Liking for sardines,36666,-0.251487157213567,0.0690171099439782,-0.386760692703764,-0.11621362172337,0.00027029169803449
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20719.Liking for sausages (meat),36666,-0.046961067356454,0.0689121281713754,-0.18202883857235,0.0881067038594419,0.495598141311518
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20720.Liking for savoury biscuits,36666,0.108579015516114,0.0685553000440167,-0.0257893725701586,0.242947403602387,0.113274730522658
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36666,-0.280602296286307,0.0682398191086329,-0.414352341739228,-0.146852250833387,3.96139300423699e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20722.Liking for skimmed milk,36666,-0.174348933320214,0.0681402325185359,-0.307903789056544,-0.0407940775838832,0.0105252066110053
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20723.Liking for smoked fish,36666,-0.192182418408896,0.0687221325267225,-0.326877798161272,-0.0574870386565199,0.00517795666030114
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20724.Liking for soft cheese,36666,-0.0866676008187811,0.0685207838163909,-0.220968337098907,0.0476331354613451,0.205966461613955
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20725.Liking for soy sauce,36666,0.0765663775860793,0.0686251488881332,-0.0579389142346619,0.21107166940682,0.26457574073236
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20726.Liking for soya milk,36666,-0.181192604527043,0.0683497427392261,-0.315158100295926,-0.0472271087581596,0.00804197377032719
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20727.Liking for spicy foods,36666,-0.0951341721343113,0.0694062221213836,-0.231170367492223,0.0409020232236006,0.170510885741148
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20728.Liking for spinach,36666,-0.229148665341103,0.0687613240554066,-0.3639208604897,-0.0943764701925059,0.000864501776092122
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20729.Liking for spirits,36666,-0.0322545951258924,0.0678686393661769,-0.165277128283599,0.100767938031814,0.634621420861459
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20730.Liking for strawberries,36666,0.112320029681717,0.0710108008964368,-0.0268611400752995,0.251501199438733,0.113750100878145
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36666,0.0641330476210416,0.0685219631351639,-0.0701700001238797,0.198436095365963,0.349327612977046
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20732.Liking for sweet foods,36666,0.0674329219060929,0.0680549178483631,-0.0659547170766988,0.200820560888885,0.321783515655578
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20733.Liking for taking the stairs,36666,-0.213055100761337,0.069682543054582,-0.349632885148318,-0.0764773163743566,0.00223915638314926
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20734.Liking for tea with sugar,36666,0.0223354369385873,0.0753247125612853,-0.125300999681532,0.169971873558706,0.766839085862008
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20735.Liking for tea without sugar,36666,-0.143279380738991,0.0698837505350041,-0.280251531787599,-0.00630722969038261,0.0403720216287717
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20736.Liking for tomato ketchup,36666,0.0368374735236152,0.0683236266770748,-0.0970768347634515,0.170751781810682,0.589790275481466
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20737.Liking for tinned tuna,36666,-0.0448414238546877,0.0682999942538639,-0.178709412592261,0.0890265648828856,0.51149788535577
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20738.Liking for turnip (white),36666,-0.000980409733374449,0.0680822724598709,-0.134421663754721,0.132460844287972,0.988510922867285
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20739.Liking for vegetables,36666,-0.022211561393221,0.0712583054850551,-0.161877840143929,0.117454717357487,0.755272885889348
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20740.Liking for vinegar,36666,0.0672181082142316,0.0686856823549214,-0.0674058292014144,0.201842045629878,0.327790494611709
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20741.Liking for watching television,36666,0.0924369215762626,0.0688341504954413,-0.0424780133948023,0.227351856547328,0.179344344977354
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20742.Liking for whisky,36666,-0.0764896332876804,0.0676272787859291,-0.209039099708101,0.0560598331327406,0.258068959363858
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20743.Liking for white bread,36666,0.142940922628434,0.0679842915769802,0.00969171113755274,0.276190134119315,0.0355353619528305
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20744.Liking for white rice,36666,0.00546915894098167,0.0684210498514837,-0.128636098767926,0.13957441664989,0.936291841086027
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20745.Liking for white wine,36666,-0.134026317672683,0.0683032632929545,-0.267900713726873,-0.000151921618491702,0.0497707535306822
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36666,-0.202142225419434,0.0686537604259386,-0.336703595854273,-0.067580854984594,0.00324535015013651
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20747.Liking for whole milk,36666,0.135218597221963,0.0678724477922092,0.00218859954923278,0.268248594894693,0.046377786642975
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20748.Liking for wholemeal bread,36666,-0.103479154802292,0.0700837616063312,-0.240843327550701,0.033885017946117,0.139846956453268
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20749.Liking for working up a sweat,36666,-0.419904390602182,0.068645446794833,-0.554449466320054,-0.285359314884309,9.98004130277533e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X21001.Body mass index (BMI),52232,-0.0521749084277213,0.0106823606939495,-0.0731123353878623,-0.0312374814675803,1.04522112657048e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X21002.Weight,52263,-0.0091480525656031,0.0051294710355522,-0.0192018157952854,0.000905710664079224,0.0745291450344762
PLA2G15,Phospholipase A2 group XV,Physical measures,X21021.Pulse wave Arterial Stiffness index,36552,0.0195464272527395,0.0038507179686368,0.0119990200342113,0.0270938344712676,3.94104823595944e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36419,0.212786256653578,0.0747724076873702,0.0662323375863328,0.359340175720824,0.00444172991185917
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36421,-0.00483446334131533,0.0762476679180334,-0.154279892460661,0.14461096577803,0.949445836103457
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36422,-0.0559889759941802,0.073957484412024,-0.200945645441747,0.0889676934533868,0.449047073511932
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21040.Satisfaction with bowel habits,36393,0.140224405934717,0.0685191846163782,0.00592680408661614,0.274522007782819,0.040740872407673
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36393,0.254555554355627,0.0751726404232025,0.10721717912615,0.401893929585104,0.000711978465388122
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21042.Greatest number of times bowels opened per day,36390,-0.0168000148700543,0.0745216593970495,-0.162862467288271,0.129262437548163,0.821644456429919
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21043.Least number of times bowels opened per week,36357,-0.140484513794655,0.0746425660997215,-0.286783943350109,0.00581491576079915,0.0598603207618694
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21044.Average number of times bowels opened per day,36366,0.150223153002189,0.0814037044513855,-0.00932810772252696,0.309774413726904,0.0650161044994225
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36428,-0.0980460000722209,0.0746811591052754,-0.244421071918561,0.0483290717741188,0.189268196360283
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36424,-0.141479346970077,0.0745078542528902,-0.287514741305742,0.00455604736558729,0.0576207681145298
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36426,-0.0606307665384465,0.0861974497842822,-0.22957776811564,0.108316235038747,0.481831190024463
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36426,-0.159684088027524,0.107314715075512,-0.370020929575528,0.0506527535204793,0.136791700360173
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36426,-0.256443457407154,0.091031122200559,-0.43486445692025,-0.0780224578940587,0.00485813879086234
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36424,-0.543541593051012,0.2149256635098,-0.964795893530221,-0.122287292571804,0.011459110994204
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36428,-0.144994528477364,0.0923447326950803,-0.325990204559721,0.0360011476049938,0.116422034975229
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36425,-0.300998208770521,0.0846877267512942,-0.466986153203057,-0.135010264337984,0.000381348340974328
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36281,0.267861546025727,0.0848041339527315,0.101645443478374,0.434077648573081,0.00159148607833014
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36422,-0.112868927082484,0.0764270071045059,-0.262665861007315,0.036928006842348,0.139764175786578
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36427,-0.223439696255759,0.128804228597576,-0.475895984307009,0.0290165917954911,0.0828291990567425
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36428,-0.322218328801057,0.07532884238924,-0.469862859883967,-0.174573797718146,1.91260648150365e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36427,-0.188447131346855,0.0748571019644521,-0.335167051197181,-0.0417272114965292,0.0118414247032968
PLA2G15,Phospholipase A2 group XV,Working and living environment,X21100.Water hardness (USGS classification),52096,-0.0210526183547653,0.040030423450055,-0.0995122483168731,0.0574070116073425,0.598951914331705
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2139.Age first had sexual intercourse,49253,-0.00800044428145354,0.00210110677023612,-0.0121186135511163,-0.00388227501179076,0.000140654518140651
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2149.Lifetime number of sexual partners,47572,0.0246862453975316,0.0461850563203747,-0.0658364649904028,0.115208955785466,0.592996929311837
PLA2G15,Phospholipase A2 group XV,Physical activities,X22032.IPAQ activity group,48457,-0.409805854089385,0.0439370389705387,-0.495922450471641,-0.323689257707129,1.19894525594665e-20
PLA2G15,Phospholipase A2 group XV,Physical activities,X22033.Summed days activity,48862,-0.0180610614354173,0.00207622691249515,-0.0221304661839078,-0.0139916566869268,3.59992380132635e-18
PLA2G15,Phospholipase A2 group XV,Physical activities,X22034.Summed minutes activity,48457,-0.0184493816435555,0.00209638007126501,-0.022558286583235,-0.0143404767038761,1.47030647615327e-18
PLA2G15,Phospholipase A2 group XV,Physical activities,X22037.MET minutes per week for walking,47735,-0.00904667526106244,0.00214166152395865,-0.0132443318480214,-0.00484901867410348,2.40965646539306e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X22038.MET minutes per week for moderate activity,48457,-0.0135879208276357,0.00213230438301172,-0.0177672374183387,-0.00940860423693276,1.90169172272137e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X22039.MET minutes per week for vigorous activity,48457,-0.550271771477481,0.044174970182495,-0.636854713035171,-0.46368882991979,1.74645008701791e-35
PLA2G15,Phospholipase A2 group XV,Physical activities,X22040.Summed MET minutes per week for all activity,47735,-0.0183949004856181,0.00212071153667594,-0.0225514950975029,-0.0142383058737332,4.50296812342136e-18
PLA2G15,Phospholipase A2 group XV,Eye measures,X2217.Age started wearing glasses or contact lenses,48530,0.00299339512476829,0.00219041997150936,-0.00129982801939006,0.00728661826892664,0.171770830972135
PLA2G15,Phospholipase A2 group XV,Working and living environment,X22501.Year ended full time education,34210,-0.0135264245185671,0.00926357275387232,-0.0316830271161568,0.00463017807902267,0.144298361171083
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X22506.Tobacco smoking,34172,-0.217417835667315,0.162214711720694,-0.535358670639874,0.100522999305245,0.180199578333415
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50884,0.0449949314122559,0.123138291484691,-0.196356119897739,0.286345982722251,0.714815099057032
PLA2G15,Phospholipase A2 group XV,Physical measures,X23098.Weight,51816,-0.00902638704865976,0.00517189636772411,-0.019163303929399,0.00111052983207949,0.0809500523962542
PLA2G15,Phospholipase A2 group XV,Physical measures,X23099.Body fat percentage,51786,0.0593014706552614,0.00459343778953292,0.0502983325877769,0.0683046087227459,5.3420329492574e-38
PLA2G15,Phospholipase A2 group XV,Physical measures,X23100.Whole body fat mass,51744,0.0517467390590172,0.0045941074807036,0.0427422883968382,0.0607511897211963,2.36346351284337e-29
PLA2G15,Phospholipase A2 group XV,Physical measures,X23101.Whole body fat-free mass,51810,-0.0291530982971252,0.0044564030395573,-0.0378876482546575,-0.0204185483395929,6.20300927954629e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23102.Whole body water mass,51816,-0.0294517924451179,0.00444458929103309,-0.0381631874555428,-0.0207403974346931,3.51419273680982e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23104.Body mass index (BMI),51816,-0.0495330130687145,0.010568098841617,-0.0702464867982839,-0.0288195393391451,2.78769209561509e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23105.Basal metabolic rate,51816,-0.0291244817343477,0.00463106761268105,-0.0382013742552026,-0.0200475892134929,3.25349591454339e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23106.Impedance of whole body,51816,0.0545384507713313,0.00363628457592966,0.0474113330025092,0.0616655685401534,1.29869067934358e-50
PLA2G15,Phospholipase A2 group XV,Physical measures,X23107.Impedance of leg (right),51816,0.0386249303521879,0.00294199497801708,0.0328586201952744,0.0443912405091014,3.10666311565572e-39
PLA2G15,Phospholipase A2 group XV,Physical measures,X23108.Impedance of leg (left),51816,0.0397798424016495,0.00293309745211538,0.0340309713955034,0.0455287134077957,9.6515503886653e-42
PLA2G15,Phospholipase A2 group XV,Physical measures,X23109.Impedance of arm (right),51816,0.0417123129438273,0.0036046946665965,0.0346471113972982,0.0487775144903565,6.97242853378037e-31
PLA2G15,Phospholipase A2 group XV,Physical measures,X23110.Impedance of arm (left),51816,0.0418104043188151,0.00360034443622391,0.0347537292238162,0.0488670794138139,4.3202631309054e-31
PLA2G15,Phospholipase A2 group XV,Physical measures,X23111.Leg fat percentage (right),51816,0.038020770059269,0.00469735471599444,0.0288139548159199,0.0472275853026181,6.05069647839971e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X23112.Leg fat mass (right),51816,0.0419641225889044,0.00505876587087955,0.0320489414819804,0.0518793036958283,1.14106822823041e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X23113.Leg fat-free mass (right),51815,-0.0307957809920459,0.00489965982075131,-0.0403991142407184,-0.0211924477433733,3.33062988723033e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23114.Leg predicted mass (right),51815,-0.0304906782399852,0.00493601311231293,-0.0401652639401186,-0.0208160925398519,6.63375200167078e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X23115.Leg fat percentage (left),51815,0.0400578183230975,0.00491646971706435,0.0304215376776514,0.0496940989685436,3.89521697182425e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X23116.Leg fat mass (left),51815,0.0428166793630619,0.00535902951966243,0.0323129815045235,0.0533203772216002,1.41593714954247e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X23117.Leg fat-free mass (left),51814,-0.0295787746032732,0.00533268271581857,-0.0400308327262776,-0.0191267164802688,2.94289153551202e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23118.Leg predicted mass (left),51814,-0.0290129322308696,0.00537488631220119,-0.0395477094027839,-0.0184781550589553,6.80980680939418e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23119.Arm fat percentage (right),51814,0.0473704031948333,0.00517248894526088,0.037232324862122,0.0575084815275446,5.70440703987584e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X23120.Arm fat mass (right),51813,0.0286137654432201,0.00566139299132315,0.0175174351802268,0.0397100957062135,4.35499163403927e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23121.Arm fat-free mass (right),51812,-0.0293327906392702,0.00489502938834395,-0.0389270482404244,-0.0197385330381161,2.0986369133772e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X23122.Arm predicted mass (right),51812,-0.0288178505082208,0.00491592487821741,-0.0384530632695269,-0.0191826377469147,4.63114992059137e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X23123.Arm fat percentage (left),51810,0.0445720421949068,0.00486972757400803,0.0350273761498511,0.0541167082399626,5.98838978563733e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X23124.Arm fat mass (left),51810,0.0287131936375938,0.00544123169621989,0.0180483795130028,0.0393780077621848,1.32519390711569e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23125.Arm fat-free mass (left),51806,-0.029201958036789,0.00445520046122928,-0.0379341509407984,-0.0204697651327796,5.69709312961739e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23126.Arm predicted mass (left),51805,-0.0291669314069968,0.00448030180900372,-0.037948322952644,-0.0203855398613495,7.66676240551293e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23127.Trunk fat percentage,51803,0.0503006158176246,0.00388866164202911,0.0426788389992475,0.0579223926360016,3.86005375191776e-38
PLA2G15,Phospholipase A2 group XV,Physical measures,X23128.Trunk fat mass,51803,0.0444622862420239,0.00410520401362112,0.0364160863753265,0.0525084861087213,2.86157459345056e-27
PLA2G15,Phospholipase A2 group XV,Physical measures,X23129.Trunk fat-free mass,51802,-0.0262401022312176,0.00386381503908789,-0.0338131797078299,-0.0186670247546053,1.13858384491247e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23130.Trunk predicted mass,51800,-0.0258701121354897,0.00386113688784109,-0.0334379404356583,-0.0183022838353212,2.13006238432864e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23400.Total Cholesterol,42181,-0.0112215239548084,0.00276015719844179,-0.0166314320637543,-0.00581161584586254,4.81919032440214e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42181,-0.0106680386591604,0.00269818329503374,-0.0159564779174265,-0.00537959940089426,7.73143771849115e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42181,-0.00186315643552659,0.00271618207262115,-0.00718687329786404,0.00346056042681086,0.492758358033958
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23403.VLDL Cholesterol,42181,0.00514770019009534,0.00280294675501693,-0.000346075449737842,0.0106414758299285,0.0663009211225397
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23404.Clinical LDL Cholesterol,42181,-0.0203358125173906,0.00268758249114893,-0.0256034742000425,-0.0150681508347387,4.07787253899514e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23405.LDL Cholesterol,42181,-0.018032038766798,0.00267601701041235,-0.0232770321072062,-0.0127870454263898,1.66610454415285e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23406.HDL Cholesterol,42181,-0.0131880192127788,0.00305518221034641,-0.0191761763450577,-0.00719986208049981,1.59568570245302e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23407.Total Triglycerides,42181,0.0289345053660219,0.00283852472734282,0.02337099690043,0.0344980138316138,2.59321213245895e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23408.Triglycerides in VLDL,42181,0.0230950668275348,0.00288627180915349,0.017437974081594,0.0287521595734757,1.32615171555914e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23409.Triglycerides in LDL,42181,0.0373914382346675,0.00266205094764866,0.0321738183772761,0.0426090580920589,1.66690767239464e-44
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23410.Triglycerides in HDL,42181,0.0501170782957796,0.00275257088473661,0.0447220393616959,0.0555121172298634,3.34224929363715e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42181,0.0113679068662047,0.00277366579946457,0.0059315218992541,0.0168042918331552,4.18228762540601e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23412.Phospholipids in VLDL,42181,0.0155203104816143,0.00282975954668326,0.00997398177011506,0.0210666391931135,4.21638650101203e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23413.Phospholipids in LDL,42181,-0.0162967959091489,0.00268604584916115,-0.0215614457735047,-0.011032146044793,1.33613906330426e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23414.Phospholipids in HDL,42181,0.014759849107251,0.0029257713720276,0.00902533721807694,0.0204943609964251,4.59925931713704e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23415.Total Esterified Cholesterol,42181,-0.0127213703662589,0.00277412932844193,-0.0181586638500051,-0.00728407688251268,4.56473436651852e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42181,0.00102747548388434,0.00278760816313402,-0.00443623651585833,0.00649118748362702,0.712441504869374
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42181,-0.0155155673222208,0.0026769548534224,-0.0207623988349287,-0.0102687358095129,6.94329145894647e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42181,-0.0183088032847613,0.0030556061893065,-0.024297791415802,-0.0123198151537205,2.12687732556822e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23419.Total Free Cholesterol,42181,-0.00744591774161525,0.00272797434525033,-0.0127927474583059,-0.00209908802492461,0.00635183797568632
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23420.Free Cholesterol in VLDL,42181,0.0100913357682018,0.00282100172789994,0.00456217238151787,0.0156204991548856,0.000348479569025518
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23421.Free Cholesterol in LDL,42181,-0.0243931644029914,0.00268571268040174,-0.0296571612565788,-0.019129167549404,1.20497632877521e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23422.Free Cholesterol in HDL,42181,0.00532380312218469,0.00303926512376992,-0.000633156520404353,0.0112807627647737,0.0798523695870678
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42181,0.00778538410497512,0.00266699006363675,0.0025580835802471,0.0130126846297031,0.00351546704167868
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23424.Total Lipids in VLDL,42181,0.0180808104569004,0.00283161479954301,0.0125308454497961,0.0236307754640047,1.76587547336741e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23425.Total Lipids in LDL,42181,-0.0142225589129672,0.00267816054046849,-0.0194717535722854,-0.00897336425364895,1.11005960527455e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23426.Total Lipids in HDL,42181,0.00695571317371196,0.00297568423207716,0.00112337207884073,0.0127880542685832,0.0194267525162351
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42181,-0.0048259760786506,0.00282277481865223,-0.010358614723209,0.000706662565907761,0.0873522046114115
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23428.Concentration of VLDL Particles,42181,0.0117882931471024,0.00279414085686801,0.00631177706764107,0.0172648092265637,2.47054254967602e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23429.Concentration of LDL Particles,42181,-0.0147925556529688,0.00269434414057617,-0.0200734701684981,-0.00951164113743949,4.08628955572367e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23430.Concentration of HDL Particles,42181,-0.00398654937791454,0.00282558639657328,-0.00952469871519817,0.00155159995936909,0.158304362393496
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42181,0.00963940762282052,0.00293678438480344,0.00388331022860578,0.0153955050170353,0.00103223938262039
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23432.Average Diameter for LDL Particles,42181,-0.0321095307881151,0.0027694836774524,-0.0375377187959218,-0.0266813427803084,6.17745320402383e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23433.Average Diameter for HDL Particles,42181,0.00390538797007694,0.0030674248487914,-0.0021067647335542,0.00991754067370807,0.202975505389009
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23434.Phosphoglycerides,42172,0.0162422184118057,0.00277814428395819,0.0107970556152476,0.0216873812083637,5.13788531582969e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42172,0.0292294830599256,0.00299501992507016,0.0233592440067881,0.0350997221130631,1.9934151976592e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23436.Total Cholines,42172,0.0109268390886971,0.00282717224066065,0.00538558149700224,0.016468096680392,0.000111635831594852
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23437.Phosphatidylcholines,42172,0.0146591684589127,0.0028368060581048,0.00909902858502725,0.0202193083327981,2.40623640339071e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23438.Sphingomyelins,42172,-0.00624492474180665,0.00285353997670364,-0.0118378630961458,-0.000651986387467521,0.0286513961141291
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23439.Apolipoprotein B,42181,-0.010106010014888,0.00270498822991631,-0.015407786945524,-0.00480423308425202,0.000187688224559114
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23440.Apolipoprotein A1,42181,0.00682324132288131,0.00291136638543296,0.0011169632074327,0.0125295194383299,0.0191101156412402
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42181,-0.0128611882063257,0.00276449627606094,-0.0182796009074051,-0.00744277550524623,3.3139739735685e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23442.Total Fatty Acids,42172,0.018460483340637,0.00259556297769158,0.0133731799043615,0.0235477867769125,1.19819399158017e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23443.Degree of Unsaturation,42172,-0.079465395507022,0.00273632562770291,-0.0848285937373197,-0.0741021972767243,6.02398764438268e-180
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23444.Omega-3 Fatty Acids,42172,-0.0349444472720631,0.00271825305202439,-0.0402722232540309,-0.0296166712900953,1.32780243300974e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23445.Omega-6 Fatty Acids,42172,-0.00895641080252598,0.00269143668110437,-0.0142316266974905,-0.00368119490756141,0.000877852176398509
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42172,-0.0160443670520331,0.00270111148770964,-0.021338545567944,-0.0107501885361222,2.92151323478633e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42172,0.0291829740172926,0.00263948641051284,0.0240095806526874,0.0343563673818977,2.69845770823602e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23448.Saturated Fatty Acids,42172,0.0323050951113674,0.00254981530505516,0.0273074571134593,0.0373027331092755,1.40430769989874e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23449.Linoleic Acid,42172,-0.00612745951264491,0.00268829234741019,-0.0113965125135689,-0.000858406511720936,0.0226639225893218
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23450.Docosahexaenoic Acid,42172,-0.0456535619417804,0.00268661724348731,-0.0509193317390155,-0.0403877921445452,4.25537511927271e-64
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42172,-0.054958590582205,0.00270445500822183,-0.0602593223983197,-0.0496578587660902,1.83139213269714e-90
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42172,-0.0488415582353243,0.0026616151233976,-0.0540583238771836,-0.043624792593465,2.5917042583833e-74
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42172,-0.0686540240653106,0.00269612411043578,-0.0739384273217647,-0.0633696208088565,9.20935552344787e-140
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42172,0.046006817736006,0.00287617083943125,0.0403695228907207,0.0516441125812912,4.53557896907915e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42172,0.0640963382615212,0.00244955756172386,0.0592952054405424,0.0688974710824999,2.78869183785215e-147
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42172,-0.0419498813856987,0.00273800907085226,-0.0473163791645692,-0.0365833836068283,1.51582736670999e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42172,-0.0552203271889672,0.00264751602190899,-0.0604094585919088,-0.0500311957860256,4.02736740619465e-95
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42172,-0.0597219147965311,0.00282694287717205,-0.0652627228357883,-0.0541811067572739,1.69160441055574e-97
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42172,0.0355519971299095,0.00269232523135198,0.0302750396764596,0.0408289545833594,1.44083842830626e-39
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23460.Alanine,42178,0.0229934042973369,0.00270648041777967,0.0176887026784887,0.028298105916185,2.17075665283136e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23461.Glutamine,42143,-0.0113888020110981,0.00265872230811192,-0.0165998977349975,-0.00617770628719875,1.85193359711311e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23462.Glycine,42167,-0.00107824819350094,0.00322704690091506,-0.00740326011929446,0.00524676373229259,0.738287793678907
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23463.Histidine,42164,-0.0127970897431499,0.00267899433462287,-0.0180479186390107,-0.00754626084728908,1.79947746715523e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42170,-0.00818522403851549,0.00300500321069569,-0.014075030331479,-0.00229541774555194,0.00646053747077395
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23465.Isoleucine,42179,-0.00600996942161014,0.00290063056951087,-0.0116952053378514,-0.000324733505368843,0.038288682218128
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23466.Leucine,42179,-0.0121181249239629,0.00298020647076151,-0.0179593296066555,-0.00627692024127039,4.80548404952266e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23467.Valine,42170,-0.00564023679507062,0.00298544512350841,-0.0114917092371471,0.00021123564700587,0.0588803293579504
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23468.Phenylalanine,42173,0.00228888584475694,0.00276327234868988,-0.00312712795867522,0.0077048996481891,0.407501386016314
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23469.Tyrosine,42167,0.0252070082052827,0.0028507550655223,0.019619528276859,0.0307944881337064,1.0527682968e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23470.Glucose,42159,0.0171770851638777,0.00260466270795132,0.0120719462562931,0.0222822240714623,4.41773952658316e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23471.Lactate,42161,0.0369461117612242,0.00272524642614337,0.0316046287659832,0.0422875947564653,1.34439647728352e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23472.Pyruvate,42141,0.0167579199358504,0.00262546757037465,0.0116120034979161,0.0219038363737847,1.79507261288728e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23473.Citrate,42179,0.0142189513045032,0.00272452599658261,0.00887888035120125,0.0195590222578051,1.82669008084453e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23474.3-Hydroxybutyrate,41900,0.00749045669532186,0.00297441481048914,0.00166060366676315,0.0133203097238806,0.0118040587458676
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23475.Acetate,42169,-0.0135257388790168,0.00260559247604319,-0.0186327001320615,-0.00841877762597215,2.1214104222296e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23476.Acetoacetate,42180,-0.00621609368666672,0.00273542103248923,-0.0115775189103456,-0.000854668462987826,0.0230752106617161
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23477.Acetone,42180,-0.0144881524050237,0.00271523221991444,-0.019810007556056,-0.00916629725399136,9.6609750508923e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23478.Creatinine,41923,-0.0206388650675258,0.00326971351492125,-0.0270475035567714,-0.0142302265782801,2.83940246446727e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23479.Albumin,42179,-0.0130835657129991,0.0027019254597236,-0.0183793396140574,-0.00778779181194085,1.29751404824912e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23480.Glycoprotein Acetyls,42181,0.02500910545458,0.00280777278763818,0.0195058707908091,0.0305123401183508,5.89654885823766e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42181,0.0348453108557282,0.00285153266551702,0.0292563068313148,0.0404343148801415,3.68021641896987e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42181,0.0349606207150898,0.00283426902889196,0.0294054534184616,0.040515788011718,9.01234280611761e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42181,0.036378206373472,0.00292881062110812,0.0306377375561001,0.0421186751908439,3.13028008423296e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42181,0.0336678714945871,0.00288218291032182,0.0280187929903563,0.0393169499988179,2.24184681558136e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42181,0.0322119685896542,0.00288353178232254,0.026560246296302,0.0378636908830064,7.5512902767775e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42181,0.0344353430200382,0.00286203140260241,0.0288257614709375,0.0400449245691389,3.56654124095328e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42181,0.0334974414047127,0.00277912125491928,0.0280503637450709,0.0389445190643545,2.75684908325942e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42181,0.0254634202828406,0.00297870186502459,0.0196251646273924,0.0313016759382888,1.37903430114646e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42181,0.0248107759755211,0.00295743784853325,0.019014197792396,0.0306073541586463,5.37030970582347e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42181,0.0250856676960114,0.00295720754479366,0.0192895409082158,0.0308817944838069,2.42190590946579e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42181,0.0158371570741811,0.00294358672904268,0.0100677270852575,0.0216065870631048,7.56271536296224e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42181,0.00811849034484401,0.00294234622797392,0.00235149173801513,0.0138854889516729,0.00580225506907275
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42181,0.0223824722582638,0.00293381030174821,0.0166322040668373,0.0281327404496903,2.52005972856785e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42181,0.0272416873869885,0.00296422822195215,0.0214318000719623,0.0330515747020147,4.48499838385624e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42181,0.0176593724196174,0.002939811235604,0.0118973423978336,0.0234214024414012,1.93847688945314e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23496.Total Lipids in Large VLDL,42181,0.0144880199029579,0.00293268759391032,0.00873995221889371,0.0202360875870222,7.8977594506646e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23497.Phospholipids in Large VLDL,42181,0.0200050679924358,0.00298699768321334,0.0141505525333376,0.0258595834515339,2.20532588230067e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23498.Cholesterol in Large VLDL,42181,0.0101896828131647,0.00295682565844177,0.00439430452261878,0.0159850611037105,0.000570342197936594
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42181,0.00332055692533353,0.0029363885758921,-0.002434764683415,0.00907587853408205,0.258146528839396
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42181,0.0158897816585495,0.00298174989601082,0.0100455518623683,0.0217340114547307,1.00326476669639e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23501.Triglycerides in Large VLDL,42181,0.0131626726692735,0.00289213264905545,0.00749409267712486,0.0188312526614222,5.3803732043648e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42181,-0.00596228907564965,0.00277095081928388,-0.0113933526814461,-0.000531225469853256,0.0314375925655984
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42181,-0.00168245360586186,0.00277913044973296,-0.00712954928733847,0.00376464207561475,0.544931008175604
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42181,-0.00518109029367957,0.00276330978456709,-0.0105971774714311,0.000234996884071928,0.0608199190764128
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42181,-0.0198378070947201,0.00270921828797135,-0.025147874939144,-0.0145277392502963,2.57400565346774e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42181,-0.0260187148971473,0.00269766528663576,-0.0313061388589534,-0.0207312909353412,6.07440403385756e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42181,-0.0104768217979517,0.00274781505137209,-0.015862539298641,-0.00509110429726244,0.000138018310774845
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42181,0.00871497748951941,0.0028563201786836,0.00311658993929956,0.0143133650397393,0.00228428855275418
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42181,0.00828184478982287,0.00286111851480878,0.00267405250079766,0.0138896370788481,0.00380224892453472
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23510.Total Lipids in Small VLDL,42181,0.00791480215878341,0.00286310710269618,0.00230311223749889,0.0135264920800679,0.00571027104361989
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23511.Phospholipids in Small VLDL,42181,-0.00387935872414963,0.00280607460928274,-0.00937926495834379,0.00162054751004454,0.166845274318539
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23512.Cholesterol in Small VLDL,42181,-0.00409005255311514,0.00283079277166939,-0.00963840638558713,0.00145830127935686,0.148524918788666
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42181,0.000626562761937015,0.00288178317518542,-0.00502173226142641,0.00627485778530044,0.827882834930696
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42181,-0.0115599577834289,0.00275071309229268,-0.0169513554443226,-0.0061685601225353,2.65634577597275e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23515.Triglycerides in Small VLDL,42181,0.0214554275839901,0.00288528523638039,0.0158002685206845,0.0271105866472956,1.09864759755146e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42181,0.0191804664326018,0.00272946218211661,0.0138307205556533,0.0245302123095504,2.20772424417042e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42181,0.0206202255285343,0.00274830733379479,0.0152335431542966,0.0260069079027721,6.63051415500609e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42181,0.0225744146414226,0.00273862639713368,0.0172067069030406,0.0279421223798046,1.83290841128281e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42181,0.00726301232496152,0.00276964586353442,0.00183450643243407,0.012691518217489,0.0087420243390752
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42181,0.00396075181631158,0.00278916241983986,-0.00150600652657455,0.00942751015919771,0.15561589990386
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42181,0.0143660962088578,0.0027453590616813,0.00898519244796245,0.0197469999697531,1.69386346570907e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42181,0.0382448034808442,0.00278504220191593,0.032786120765089,0.0437034861965994,1.25405955699606e-42
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23523.Concentration of IDL Particles,42181,-0.00405129970422866,0.00270785259479635,-0.0093586907900295,0.00125609138157218,0.134642999055632
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23524.Total Lipids in IDL,42181,-0.00507962027354255,0.00276531734693943,-0.0104996422735438,0.000340401726458735,0.0662460266289623
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23525.Phospholipids in IDL,42181,-0.00539805857377906,0.00276456760440969,-0.0108166110784221,2.04939308639327e-05,0.0508890752424477
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23526.Cholesterol in IDL,42181,-0.0110158274815596,0.00277796113723757,-0.0164606313105452,-0.00557102365257392,7.36375392928604e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42181,-0.0104883573285296,0.00278136346273735,-0.0159398297154948,-0.00503688494156437,0.00016332277999489
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23528.Free Cholesterol in IDL,42181,-0.0121941240437993,0.00275972945904717,-0.0176031937835317,-0.00678505430406685,1.00114528872693e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23529.Triglycerides in IDL,42181,0.0417194535028841,0.00268395576678748,0.0364589001999807,0.0469800068057876,5.09703575017591e-54
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23530.Concentration of Large LDL Particles,42181,-0.0185738315195859,0.00268049843291647,-0.0238276084481022,-0.0133200545910696,4.42161240744349e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23531.Total Lipids in Large LDL,42181,-0.0152020013890393,0.00269016551308699,-0.0204747257946898,-0.00992927698338879,1.62767151356258e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23532.Phospholipids in Large LDL,42181,-0.0164790593645516,0.00269823599036408,-0.0217676019056652,-0.011190516823438,1.04065884629404e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23533.Cholesterol in Large LDL,42181,-0.0193178772215392,0.00268940780748619,-0.0245891165242121,-0.0140466379188662,7.17762693670274e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42181,-0.0181421842780656,0.00268601990049721,-0.0234067832830401,-0.012877585273091,1.49367034502688e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42181,-0.0222311710729603,0.00271098185775164,-0.0275446955141536,-0.0169176466317671,2.60926060808591e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23536.Triglycerides in Large LDL,42181,0.0393722042663474,0.00265512234718168,0.0341681644658713,0.0445762440668235,2.32140079639065e-49
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42181,-0.00943133985336383,0.00271449661608867,-0.0147517532208976,-0.00411092648583004,0.000513528744658467
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23538.Total Lipids in Medium LDL,42181,-0.012475715195948,0.00269297341708967,-0.0177539430934438,-0.00719748729845226,3.64294933380014e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23539.Phospholipids in Medium LDL,42181,-0.0153723656131872,0.00270129139833759,-0.0206668967539289,-0.0100778344724455,1.29098283023057e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23540.Cholesterol in Medium LDL,42181,-0.0153320613819728,0.00268832533163243,-0.0206011790319724,-0.0100629437319733,1.20028057336229e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42181,-0.0110128657640947,0.00270092740857836,-0.0163066834849083,-0.00571904804328111,4.57940700544367e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42181,-0.0262905714881348,0.00266744998140596,-0.0315187734516905,-0.0210623695245791,7.69768042080435e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23543.Triglycerides in Medium LDL,42181,0.0338697858150267,0.00268086282131063,0.0286152946852578,0.0391242769447955,2.19902752655265e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23544.Concentration of Small LDL Particles,42181,-0.00600991830925424,0.00271701453475134,-0.0113352667973669,-0.000684569821141603,0.0269862436434817
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23545.Total Lipids in Small LDL,42181,-0.0129170679326814,0.00267422571175147,-0.0181585503277143,-0.00767558553764849,1.37878443162301e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23546.Phospholipids in Small LDL,42181,-0.0161830559898935,0.00266325676364102,-0.0214030392466299,-0.0109630727331571,1.26185136624944e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23547.Cholesterol in Small LDL,42181,-0.0165246436898503,0.00268066173953701,-0.0217787406993428,-0.0112705466803577,7.27583200034051e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42181,-0.0102519343685406,0.00268503405026241,-0.0155146011070549,-0.00498926763002627,0.000135039105933522
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42181,-0.0310862656804838,0.00266853809112237,-0.0363166003390836,-0.0258559310218839,3.26070989116997e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23550.Triglycerides in Small LDL,42181,0.0310306404525339,0.0027194365870578,0.0257005447419006,0.0363607361631672,5.06637949728621e-30
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42181,0.00338952275727721,0.00312370619548722,-0.00273294138587775,0.00951198690043217,0.277898164420142
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42181,0.000653604068844976,0.00313551575346391,-0.00549200680794429,0.00679921494563424,0.834879298578424
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42181,0.00413974836540077,0.00311884434316864,-0.00197318654720976,0.0102526832780113,0.184420509540016
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42181,-0.0102617688614303,0.00317031713875184,-0.0164755904533839,-0.0040479472694767,0.00121156388905849
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42181,-0.0153504280197619,0.00318386339259707,-0.0215908002692521,-0.00911005577027162,1.44155699600453e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42181,0.00656702519336587,0.00308453165495556,0.000521343149652981,0.0126127072370788,0.0332706636172236
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42181,0.0394779313116015,0.00258462986507041,0.0344120567760635,0.0445438058471395,3.08959889739004e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23558.Concentration of Large HDL Particles,42181,-0.00916413572364774,0.00314741657363255,-0.0153330722079675,-0.00299519923932794,0.00360124656005873
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23559.Total Lipids in Large HDL,42181,-0.0039937691824063,0.00312098933964187,-0.0101109082881044,0.00212336992329176,0.200690660472307
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23560.Phospholipids in Large HDL,42181,0.00290185332347987,0.00309071991960466,-0.00315595771894526,0.008959664365905,0.347802708772135
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23561.Cholesterol in Large HDL,42181,-0.0175813237257149,0.0031655099211091,-0.0237857231710888,-0.0113769242803411,2.84408028785775e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42181,-0.0222118921255334,0.00317439507234735,-0.0284337064673342,-0.0159900777837325,2.73358375604462e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42181,-0.00207335546626791,0.00313196438276674,-0.00821200565649072,0.00406529472395491,0.507983467927049
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23564.Triglycerides in Large HDL,42181,0.0505844380631188,0.00270817344981074,0.0452764181014897,0.0558924580247478,6.79881853162086e-77
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42181,0.00683235655837587,0.00288060836409994,0.00118636416473998,0.0124783489520118,0.0177133726087314
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23566.Total Lipids in Medium HDL,42181,0.011325139100493,0.00283201336361874,0.0057743929078003,0.0168758852931858,6.39553014541841e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23567.Phospholipids in Medium HDL,42181,0.0177901413631287,0.00278170043286618,0.0123380085147109,0.0232422742115464,1.65350064822148e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23568.Cholesterol in Medium HDL,42181,-0.00405845777811703,0.00291428805683121,-0.00977046236950619,0.00165354681327213,0.163761480654409
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42181,-0.0066483020301471,0.00291017308454235,-0.0123522412758501,-0.000944362784444095,0.0223572821612403
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42181,0.00667902361668848,0.00292639474289681,0.000943289920610731,0.0124147573127662,0.0224847494798797
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23571.Triglycerides in Medium HDL,42181,0.0512303796920703,0.00278215723877373,0.0457773515040738,0.0566834078800668,8.24996020942111e-75
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23572.Concentration of Small HDL Particles,42181,-0.0108617112227629,0.0026957668080214,-0.0161454141664848,-0.00557800827904096,5.62782979290262e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23573.Total Lipids in Small HDL,42181,0.00736168687544262,0.00269500570590841,0.00207947569186214,0.0126438980590231,0.00631083600827249
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23574.Phospholipids in Small HDL,42181,0.0145987279106461,0.00267872993331584,0.00934841724134708,0.0198490385799452,5.12861255881803e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23575.Cholesterol in Small HDL,42181,-0.014327189487068,0.00268098188359801,-0.0195819139789201,-0.00907246499521586,9.23823187859249e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42181,-0.0212923973402297,0.00269413072555745,-0.0265728935623223,-0.0160119011181371,2.92550318099619e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42181,0.0079448208066361,0.00267282712015582,0.00270607965113069,0.0131835619621415,0.00295960193964967
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23578.Triglycerides in Small HDL,42181,0.0440588608723589,0.0030100753007747,0.0381591132828405,0.0499586084618773,3.78603927184685e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41802,-0.00375877054221817,0.0030477847075996,-0.00973242856911338,0.00221488748467704,0.21749344379561
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41802,-0.028193122980103,0.00291573536881865,-0.0339079643029876,-0.0224782816572185,4.81759535168892e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41802,-0.0244329513580017,0.00295487181431587,-0.0302245001140608,-0.0186414026019426,1.48296260997805e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41802,-0.0282940512007336,0.0029141819998816,-0.0340058479205015,-0.0225822544809656,3.27230037517427e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41802,0.0241321493586901,0.00295515768727526,0.0183400402916306,0.0299242584257497,3.47238199412055e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42108,0.00232358871494879,0.00298374563116003,-0.00352455272212486,0.00817173015202245,0.43614126869119
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42108,-0.0368102113576235,0.00299237973580709,-0.0426752756398054,-0.0309451470754416,1.36465650740947e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42108,-0.0384917424149176,0.00297238920174181,-0.0443176252503315,-0.0326658595795037,3.97343977044949e-38
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42108,-0.0224058424333986,0.00301377159874416,-0.0283128347669371,-0.01649885009986,1.11289811864085e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42108,0.0309028094308191,0.00298786682278173,0.0250465904581669,0.0367590284034713,5.59346348457654e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42181,0.0393675913775412,0.00309794796293353,0.0332956133701915,0.045439569384891,8.68600466464485e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42181,-0.0216731523074532,0.00290938244126641,-0.0273755418923354,-0.015970762722571,9.94205985907934e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42181,-0.0279379188308367,0.00295211561265364,-0.0337240654316378,-0.0221517722300356,3.45454416833852e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42181,0.00156777620651121,0.00296030906636227,-0.00423442956355884,0.00736998197658126,0.596398765212914
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42181,0.00515290018026162,0.0029734581605037,-0.000675077814325632,0.0109808781748489,0.0831245138877159
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42181,-0.0151910083732371,0.0028558095809575,-0.0207883951519138,-0.00959362159456038,1.05799765787874e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42181,-0.0299674621678289,0.00294703101305259,-0.0357436429534119,-0.0241912813822458,3.33977439598699e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42181,-0.0315272527120661,0.00296545655977696,-0.037339547569229,-0.0257149578549033,2.69808408307467e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42181,-0.0245276029814941,0.00288660298732307,-0.0301853448366473,-0.0188698611263409,2.14551664758237e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42181,0.0268525311849437,0.00292439213742429,0.0211207225955921,0.0325843397742953,4.82374925807601e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42181,-0.0410256832051303,0.00285964915117535,-0.0466305955414339,-0.0354207708688266,2.44653034223327e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42181,-0.0265430213366817,0.00277416975256432,-0.0319803940517077,-0.0211056486216556,1.27616436321534e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42181,-0.0161392400087196,0.00273904228879043,-0.0215077628947488,-0.0107707171226904,3.89895513168024e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42181,-0.0385733812933863,0.0028874621811659,-0.0442328071684714,-0.0329139554183011,1.8911683447768e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42181,0.0311627405337606,0.00279835927985894,0.025677956345237,0.0366475247222841,1.11440220315658e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42181,0.018465572183904,0.00272287668175194,0.0131287338876702,0.0238024104801378,1.23732144094253e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42181,-0.0308868258184498,0.00286245561220145,-0.0364972388183647,-0.025276412818535,4.92225731680473e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42181,-0.029974886402681,0.00290227808380635,-0.0356633514469415,-0.0242864213584206,6.50588537139942e-25
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42181,-0.0280428533304616,0.00253065013883314,-0.0330029276025746,-0.0230827790583486,2.04686416492927e-28
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42181,0.0299189543982147,0.00282765684007285,0.0243767469916719,0.0354611618047575,4.61914728607111e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42181,0.00223407168306507,0.00266285845928359,-0.00298513089713077,0.00745327426326091,0.40149810390825
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42181,-0.0352455357252653,0.00277571440457342,-0.0406859359582292,-0.0298051354923014,9.83173441342488e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42181,-0.0289608233150052,0.00274201658749012,-0.0343351758264859,-0.0235864708035246,5.6448621721661e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42181,-0.0273985534566841,0.00255694715659277,-0.032410169883606,-0.0223869370297623,1.10240395608462e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42181,0.0453967427649919,0.002784667848161,0.0399387937825963,0.0508546917473875,3.45867430602046e-59
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42181,-0.00566679972965165,0.00272828455108925,-0.0110142374497866,-0.000319362009516725,0.0378151450843306
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42181,-0.0578018410819849,0.00273455127697209,-0.0631615615848502,-0.0524421205791196,1.32972932708683e-97
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42181,-0.041643289754486,0.00263390918593912,-0.0468057517589266,-0.0364808277500453,8.28615517353021e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42181,-0.0332933996233153,0.00296909644317344,-0.0391128286519353,-0.0274739705946954,4.7065309016623e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42181,0.056595310651419,0.0026936429716828,0.0513157704269207,0.0618748508759173,1.78219840034451e-96
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42181,-0.0198296816629211,0.00280097332597848,-0.0253195893818389,-0.0143397739440033,1.51707700047159e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42181,-0.0419127410790289,0.00274721317506064,-0.0472972789021478,-0.0365282032559101,4.031562111384e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42181,0.00467116874200961,0.0028042510267439,-0.000825163270408432,0.0101675007544276,0.0957871632712255
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42181,-0.0414912772954383,0.00285884897682824,-0.0470946212900216,-0.0358879333008549,2.25768545492387e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42181,0.0553034230929974,0.00268792821349238,0.0500350837945523,0.0605717623914425,1.18855237212414e-92
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42181,-0.0115766650823374,0.00278496243534485,-0.0170351914556133,-0.00611813870906147,3.24647863135343e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42181,-0.0331311674428511,0.00270264222624369,-0.0384283462062888,-0.0278339886794135,2.28944188652412e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42181,0.0098511140350505,0.00276169887074292,0.00443818424839438,0.0152640438217066,0.000362266996461444
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42181,-0.0458029749620969,0.00271088054601653,-0.0511163008322893,-0.0404896490919045,2.13691742761297e-63
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42181,0.0495682211064079,0.00275401525233132,0.0441703512118385,0.0549660910009773,1.35560925087493e-71
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42170,0.0157966999840047,0.00296741287731277,0.00998057074447169,0.0216128292235378,1.03472648062563e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42170,-0.0360502324898351,0.00255948628688505,-0.0410668256121298,-0.0310336393675404,9.70738159242504e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42170,-0.0477484596628386,0.00236932961207953,-0.0523923457025145,-0.0431045736231628,5.08560710004967e-89
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42170,0.00717426588341312,0.00307729794757245,0.00114276190617111,0.0132057698606551,0.0197493505490143
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42170,0.0324889817981959,0.00288941783881773,0.0268257228341132,0.0381522407622787,3.33229428921472e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42181,0.04330010531208,0.00271697599716983,0.0379748323576271,0.0486253782665329,1.14633170770346e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42181,-0.0520474486794518,0.00286041797957935,-0.0576538679194273,-0.0464410294394763,4.11134964310148e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42181,-0.0573484970020691,0.00274083969091901,-0.0627205427962703,-0.0519764512078678,1.04726887724512e-95
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42181,0.00591216602726893,0.00276901364761092,0.000484899277951531,0.0113394327765863,0.0327693584372959
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42181,0.0446170496925112,0.00275327199502567,0.0392206365822609,0.0500134628027615,1.64095581811944e-58
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42181,0.0501222857371742,0.00293547430556921,0.0443687560982586,0.0558758153760899,1.0827668872477e-64
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42181,-0.0533935201752708,0.00292456897285495,-0.0591256753620665,-0.0476613649884751,1.38101722350208e-73
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42181,-0.0537698166007306,0.00277591556234827,-0.0592106111029332,-0.048329022098528,1.78123008223814e-82
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42181,-0.00999481525119795,0.00307958036798421,-0.016030792772447,-0.00395883772994891,0.00117523522836217
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42181,0.0509446173941828,0.00288418275353217,0.0452916191972597,0.0565976155911059,4.73706662333419e-69
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42181,0.0504043468559907,0.00267897793358837,0.0451535501061575,0.0556551436058239,5.5898853069261e-78
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42181,-0.0599169829972292,0.0026374719893229,-0.0650864280963021,-0.0547475378981563,3.65183122990624e-112
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42181,-0.0591757469751518,0.00259986192215906,-0.0642714763425836,-0.05408001760772,1.40472054542317e-112
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42181,6.15719205190254e-05,0.00286976391322378,-0.00556316534939958,0.00568630919043763,0.982882699480339
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42181,0.0474535930585492,0.00300872324383532,0.0415564955006319,0.0533506906164664,1.50764318674977e-55
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52020,-0.000115813530602868,0.00229600163383596,-0.00461597673292135,0.00438434967171561,0.959771078243182
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52020,0.00173838641832751,0.00222955834749929,-0.00263154794277109,0.00610832077942611,0.435575417368713
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50463,0.00197981052476177,0.00213410519603365,-0.00220303565946419,0.00616265670898773,0.3535731738478
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50463,0.00378763450488729,0.0023235156462529,-0.000766456161768385,0.00834172517154297,0.103088252933704
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50463,0.00092957889414266,0.00230506200383126,-0.00358834263336661,0.00544750042165193,0.686748274399753
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50463,-0.000518572869713597,0.00211648480543011,-0.0046668830883566,0.00362973734892941,0.8064462586069
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24009.Traffic intensity on the nearest road,52020,-0.135288479802225,0.0869651342643587,-0.305740142960368,0.0351631833559183,0.119801657739397
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24010.Inverse distance to the nearest road,52020,0.00501705235276758,0.00200157440840066,0.00109396651230228,0.00894013819323288,0.0121981984173566
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24011.Traffic intensity on the nearest major road,52020,0.00341851225288254,0.00199769464871819,-0.000496969258605107,0.00733399376437019,0.0870521590552574
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24012.Inverse distance to the nearest major road,52020,-0.000588583229800474,0.00202955963951401,-0.00456652012324793,0.00338935366364699,0.771814683442924
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24013.Total traffic load on major roads,52020,-0.108957820077238,0.0604808682236823,-0.227500321795655,0.00958468164117951,0.0716329649470129
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24015.Sum of road length of major roads within 100m,52020,-0.09082274799413,0.0586605321005167,-0.205797390911143,0.0241518949228828,0.121569151191952
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52020,-0.00234985726052119,0.00230461225252586,-0.00686689727547187,0.00216718275442949,0.307913378000194
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52020,-0.00239888037227998,0.00230471466173661,-0.00691612110928374,0.00211836036472379,0.297952266244355
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52020,-0.00237668392499499,0.00227732679425848,-0.00684024444174161,0.00208687659175162,0.296667915534982
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51982,-0.00133443733739295,0.00222634249925661,-0.00569806863593591,0.00302919396115,0.548921673922925
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24020.Average daytime sound level of noise pollution,52020,-0.000110126760966238,0.00200397769565844,-0.00403792304445677,0.0038176695225243,0.956175511959869
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24021.Average evening sound level of noise pollution,52020,-7.77652616231355e-05,0.00200412703380409,-0.00400585424787915,0.00385032372463288,0.969048133667699
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24022.Average night-time sound level of noise pollution,52020,-0.000109263897808324,0.00200404759651227,-0.00403719718697238,0.00381866939135573,0.95652005841673
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52020,-8.12196352084178e-05,0.0020040378061655,-0.0040091337352928,0.00384669446487597,0.967672533646284
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52020,-7.17079695141252e-05,0.00200407622478065,-0.0039996973700842,0.00385628143105595,0.971457241118475
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2405.Number of children fathered,52013,-0.101317357878025,0.0452197304525384,-0.189948029565001,-0.0126866861910499,0.0250641610768811
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49492,-0.000484997691444894,0.00237824073268917,-0.00514634952751566,0.00417635414462588,0.838409182270056
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49492,0.00114094207322718,0.00213935122504319,-0.00305218632785747,0.00533407047431183,0.593823168367006
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24502.Water percentage, buffer 1000m",49492,0.00357441079879814,0.00215809941510189,-0.000655464054801556,0.00780428565239783,0.0976807182333543
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49492,0.000250118389785345,0.00223389762721462,-0.00412832095955532,0.00462855773912601,0.910852218733722
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49492,0.000109127823847176,0.00215857171637289,-0.00412167274024369,0.00433992838793805,0.959680150702489
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24505.Water percentage, buffer 300m",49492,0.00183726245078578,0.00217179952975193,-0.002419464627528,0.00609398952909956,0.397582970184015
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52097,0.000305266911852488,0.0022751364244625,-0.00415400048009401,0.00476453430379899,0.893265175841329
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52097,-0.000960139096465161,0.00213160047265157,-0.00513807602286224,0.00321779782993192,0.65240379689417
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24508.Distance (Euclidean) to coast,52097,-0.00206543347253253,0.00201287983730573,-0.00601067795365176,0.00187981100858671,0.304850922459404
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2867.Age started smoking in former smokers,35525,-0.00792517187019277,0.00373546004048677,-0.0152466735495468,-0.00060367019083869,0.0339063125397404
PLA2G15,Phospholipase A2 group XV,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37065,0.19241906070713,0.0948870100021199,0.00644052110297497,0.378397600311285,0.0426042027939368
PLA2G15,Phospholipase A2 group XV,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37064,0.224777008493315,0.107911135950224,0.0132711820308759,0.436282834955754,0.037282769084845
PLA2G15,Phospholipase A2 group XV,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37064,0.398572034787416,0.100973415250926,0.200664140895601,0.59647992867923,7.96785210968665e-05
PLA2G15,Phospholipase A2 group XV,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37053,0.286482404619828,0.100871049893607,0.0887751468283572,0.484189662411298,0.00452092037322159
PLA2G15,Phospholipase A2 group XV,Mental health,X28739.Difficulty with standing for long periods,37071,0.565735103144934,0.087094981398003,0.395028939604849,0.73644126668502,8.73593476357742e-11
PLA2G15,Phospholipase A2 group XV,Mental health,X28740.Difficulty with taking care of household responsibilities,37089,0.524840622531217,0.100863935800574,0.327147308362092,0.722533936700343,2.00196357992149e-07
PLA2G15,Phospholipase A2 group XV,Mental health,X28741.Difficulty learning a new task,37041,0.584217806546645,0.118585831022484,0.351789577742577,0.816646035350714,8.52898778297887e-07
PLA2G15,Phospholipase A2 group XV,Mental health,X28742.Difficulty with joining in community activities,36613,0.544068003328888,0.108619208022835,0.331174355604132,0.756961651053645,5.58978657979505e-07
PLA2G15,Phospholipase A2 group XV,Mental health,X28743.Difficulty with being emotionally affected by health problems,37035,0.40746158412277,0.0951479706687094,0.220971561612099,0.59395160663344,1.86938249356906e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37095,0.58203670136935,0.12656264500734,0.333973917154964,0.830099485583736,4.31074402478063e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34919,0.478040605935012,0.0857537568075208,0.309963242592272,0.646117969277753,2.58395601797405e-08
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2897.Age stopped smoking,35515,0.0318427120642423,0.00390280263005618,0.0241932189093322,0.0394922052191524,3.98204968817715e-16
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36120,-0.00479082449408132,0.00742077282493446,-0.0193355392309529,0.00975389024279023,0.518560443187609
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36120,0.00136741703163609,0.00840185361155143,-0.0151002160470047,0.0178350501102769,0.870718211368495
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36120,0.0335240570014601,0.0282378967103235,-0.021822220550774,0.0888703345536942,0.23518587737952
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36120,-0.0222909963391849,0.0275759835255287,-0.0763399240492211,0.0317579313708513,0.41891573974144
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36120,-0.0165876812620101,0.034153135928929,-0.083527827682711,0.0503524651586907,0.627204350108227
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36120,-0.00874646808018275,0.0303954482578786,-0.0683215466656247,0.0508286105052592,0.773541563857397
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36120,0.00909451475826695,0.0126137249888384,-0.0156283862198563,0.0338174157363902,0.470930999142922
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36120,-0.00409908187033707,0.023715442683507,-0.0505813495300108,0.0423831857893366,0.862778374182067
PLA2G15,Phospholipase A2 group XV,Mental health,X29002.Recent lack of interest or pleasure in doing things,36071,0.331113202729712,0.103552606140957,0.128150094693436,0.534076310765988,0.00139185057306986
PLA2G15,Phospholipase A2 group XV,Mental health,X29003.Recent feelings of depression,36071,0.254952519568397,0.102871163950369,0.0533250382256736,0.45658000091112,0.0132204496543623
PLA2G15,Phospholipase A2 group XV,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36074,0.243388876495094,0.0813555319851328,0.0839320338042339,0.402845719185954,0.00278362202976256
PLA2G15,Phospholipase A2 group XV,Mental health,X29005.Recent feelings of tiredness or low energy,36077,0.348645214759655,0.080472433270686,0.19091924554911,0.5063711839702,1.49367406257963e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29006.Recent poor appetite or overeating,36082,0.598952753517496,0.124797924292463,0.354348821904269,0.843556685130723,1.62243813466675e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X29007.Recent feelings of inadequacy,36058,0.0631370236784246,0.112294564509621,-0.156960322760432,0.283234370117281,0.573966212374818
PLA2G15,Phospholipase A2 group XV,Mental health,X29008.Recent trouble concentrating on things,36078,0.205484424202171,0.106687817002997,-0.00362369712370217,0.414592545528045,0.0541379313621741
PLA2G15,Phospholipase A2 group XV,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36077,0.338404422205296,0.181893659881892,-0.0181071511632124,0.694915995573805,0.062860846299714
PLA2G15,Phospholipase A2 group XV,Mental health,X29010.Recent thoughts of suicide or self-harm,36053,0.446146962378771,0.196517484365568,0.0609726930222587,0.831321231735284,0.0232198793884
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#0.Substances taken for depression_None of options listed,35991,-0.0408789607997785,0.0153995162220006,-0.0710620125948998,-0.0106959090046572,0.00795817391114117
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35991,0.0062127879733246,0.0282896971881613,-0.0492350185154716,0.0616605944621208,0.826178556293287
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35991,-0.02933611810619,0.0169891705557592,-0.0626348923954781,0.00396265618309815,0.0842536381361297
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35991,0.00939049414593906,0.0515914615066793,-0.0917287704071524,0.110509758699031,0.855574815949702
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35991,-0.0738899067795692,0.0335298121358434,-0.139608338565822,-0.00817147499331623,0.0275756281912893
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35991,-0.0314633327384996,0.0387756289277892,-0.107463565436966,0.0445368999599673,0.417150470566906
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35991,0.0297094785118527,0.0407173549478722,-0.0500965371859767,0.109515494209682,0.465626365988497
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35991,-0.025505311950684,0.0477648637235034,-0.119124444848751,0.0681138209473827,0.593373892637767
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35991,0.0170046843347078,0.0338582313206595,-0.0493574490537847,0.0833668177232003,0.615519357848743
PLA2G15,Phospholipase A2 group XV,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35991,-0.032939762024772,0.0144728935030228,-0.0613066332906967,-0.00457289075884741,0.0228767407333475
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35991,-0.0152197393670898,0.0233548075007965,-0.060995162068651,0.0305556833344713,0.514631249065873
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35991,-0.00397798291488883,0.0378990676135266,-0.0782601554374009,0.0703041896076233,0.916408370650183
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35991,0.00129226207233857,0.045685470665278,-0.0882512604316063,0.0908357845762834,0.977434760463357
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35991,-0.0123951155443028,0.0272965712210829,-0.0658963951376252,0.0411061640490197,0.649776975115196
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35991,-0.0303203526089555,0.0421878937640229,-0.11300862438644,0.0523679191685295,0.472349768487831
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35991,-0.0236419886970629,0.0418591303046237,-0.105685884094125,0.0584019066999996,0.572227729677279
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35991,-0.0314356077320201,0.0233941491724039,-0.0772881401099317,0.0144169246458915,0.179074367129594
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35991,-0.00352873361678387,0.0225611694336985,-0.0477486257068329,0.0406911584732652,0.875716184625867
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35991,-0.0548331231538705,0.0335156388155989,-0.120523775232444,0.0108575289247033,0.101872562014898
PLA2G15,Phospholipase A2 group XV,Mental health,X29058.Recent feelings or nervousness or anxiety,35959,0.1288892134772,0.100316902201397,-0.0677319148375379,0.325510341791937,0.198895463360784
PLA2G15,Phospholipase A2 group XV,Mental health,X29059.Recent inability to stop or control worrying,35965,0.106502491337912,0.106085640612323,-0.101425364262241,0.314430346938065,0.315445645165149
PLA2G15,Phospholipase A2 group XV,Mental health,X29060.Recent worrying too much about different things,35963,0.155046811336178,0.0948281183478558,-0.0308163006256189,0.340909923297976,0.102085532309475
PLA2G15,Phospholipase A2 group XV,Mental health,X29061.Recent trouble relaxing,35960,0.221696551208014,0.100990732059995,0.0237547163704238,0.419638386045604,0.0281791728313514
PLA2G15,Phospholipase A2 group XV,Mental health,X29062.Recent restlessness,35968,0.356339157874039,0.13735703759799,0.0871193641819791,0.625558951566098,0.00949839520662472
PLA2G15,Phospholipase A2 group XV,Mental health,X29063.Recent easy annoyance or irritability,35956,0.295952418109826,0.096999254809342,0.105833878683516,0.486070957536136,0.00228833192948781
PLA2G15,Phospholipase A2 group XV,Mental health,X29064.Recent feelings of foreboding,35959,0.423294860902812,0.119907966969947,0.188275245641715,0.658314476163909,0.000417841195824498
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35991,-0.0340390315034712,0.0183743053621473,-0.07005267001328,0.00197460700633754,0.0639889722082573
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35991,-0.0283692249526763,0.0276889782269534,-0.0826396222775048,0.0259011723721523,0.305600875860535
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35991,0.0435831296234563,0.0385140877626526,-0.0319044823913427,0.119070741638255,0.257832933620869
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35991,-0.0745639430361275,0.0381764217462855,-0.149389729658847,0.00026184358659212,0.0508405462504985
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#2.Symptoms of panic attack_Sweating,35991,-0.0470239232265971,0.0236625362824056,-0.0934024943401121,-0.000645352113082039,0.0469289838453592
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35991,-0.00346533999554141,0.0297056403220263,-0.061688395026713,0.0547577150356302,0.907135860075663
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35991,-0.00464717422239507,0.0282683917648177,-0.0600532220814378,0.0507588736366477,0.869424918801086
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35991,-0.0060662123733769,0.0281668047403037,-0.0612731496643721,0.0491407249176183,0.82948680305793
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35991,-0.0328634486805078,0.0354113467845814,-0.102269688378287,0.0365427910172718,0.353412696804277
PLA2G15,Phospholipase A2 group XV,Mental health,X29076.Felt loved as a child,35930,-0.00855313909794802,0.0805455479908866,-0.166422413160086,0.14931613496419,0.915434439507042
PLA2G15,Phospholipase A2 group XV,Mental health,X29077.Physically abused by family as a child,35941,0.0861913590348782,0.104655905224644,-0.118934215205425,0.291316933275181,0.410211262170537
PLA2G15,Phospholipase A2 group XV,Mental health,X29078.Felt hated by family member as a child,35934,0.0557321830157689,0.118244521239716,-0.176027078614075,0.287491444645613,0.637419164269022
PLA2G15,Phospholipase A2 group XV,Mental health,X29079.Sexually molested as a child,35919,0.0969812144823551,0.174152848488931,-0.244358368555949,0.438320797520659,0.577630471157044
PLA2G15,Phospholipase A2 group XV,Mental health,X29080.Someone to take to doctor when needed as a child,35928,0.0385644516092891,0.125125657727315,-0.206681837536248,0.283810740754826,0.757934514246964
PLA2G15,Phospholipase A2 group XV,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35938,0.066752440332296,0.179056363449363,-0.284198032028456,0.417702912693048,0.709307123724756
PLA2G15,Phospholipase A2 group XV,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35913,0.186926070601063,0.151162122390711,-0.10935168928473,0.483203830486857,0.216277818728623
PLA2G15,Phospholipase A2 group XV,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35950,-0.117817620372503,0.171629046615864,-0.454210551739596,0.218575310994591,0.49244053197981
PLA2G15,Phospholipase A2 group XV,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35942,0.412785135509722,0.52937429499083,-0.624788482672306,1.45035875369175,0.435557031479712
PLA2G15,Phospholipase A2 group XV,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35935,0.256114591808826,0.331305961498304,-0.39324509272785,0.905474276345502,0.439520350440732
PLA2G15,Phospholipase A2 group XV,Mental health,X29086.Experienced a violent or sexual assault,35956,-0.0561875133043348,0.184689090694556,-0.418178131065665,0.305803104456995,0.760963128347832
PLA2G15,Phospholipase A2 group XV,Mental health,X29087.Experienced a life-threatening injury or illness,35949,0.292021022873393,0.0931589132871981,0.109429552830485,0.474612492916302,0.00172734399252919
PLA2G15,Phospholipase A2 group XV,Mental health,X29088.Experienced a marital separation or divorce,35946,0.0570027229462403,0.0922298713503534,-0.123767824900452,0.237773270792933,0.536561178533712
PLA2G15,Phospholipase A2 group XV,Mental health,X29089.Experienced the death of a spouse or partner,35957,0.244706039854794,0.140168725337857,-0.0300246618074061,0.519436741516994,0.0808881043515643
PLA2G15,Phospholipase A2 group XV,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35950,0.107987562911522,0.112468589415987,-0.112450872343813,0.328425998166857,0.337007526374115
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29091.Frequency of drinking alcohol,35944,-0.12286719080667,0.0755330589605259,-0.2709119863693,0.0251776047559611,0.103850602218943
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35346,0.0383611164540623,0.0800838975661929,-0.118603322775676,0.1953255556838,0.63194590431522
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35365,-0.0459749911661201,0.0799402861590976,-0.202657952037951,0.110707969705711,0.565231529536035
PLA2G15,Phospholipase A2 group XV,Mental health,X29104.Ever used cannabis,35938,-0.15041858452159,0.100333681827723,-0.347072600903928,0.0462354318607481,0.133869110832814
PLA2G15,Phospholipase A2 group XV,Mental health,X29108.Ever thought that life not worth living,35911,0.0565613152698863,0.100734826173264,-0.140878944029711,0.254001574569484,0.574482667907917
PLA2G15,Phospholipase A2 group XV,Mental health,X29109.Ever contemplated self-harm,35918,0.051093491155265,0.141409127589445,-0.226068398920047,0.328255381230577,0.717873080501109
PLA2G15,Phospholipase A2 group XV,Mental health,X29111.Ever self-harmed,35931,0.139178964149301,0.24620279748175,-0.343378518914928,0.62173644721353,0.571885586377897
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35932,-0.150800220934705,0.151190577393134,-0.447133752625247,0.145533310755837,0.318594521374612
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36584,-0.0338149283406162,0.0371155290690996,-0.106561365316051,0.038931508634819,0.362284815564254
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36584,-0.0464404269013917,0.028729578337173,-0.102750400442251,0.00986954663946739,0.106032803494868
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36584,-0.0495173862180145,0.0361536105007115,-0.120378462799409,0.0213436903633801,0.17083821365313
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36584,0.0625860544616576,0.0595247478353991,-0.0540824512957247,0.17925456021904,0.293093359699362
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35921,-0.243530053265206,0.0866764046981991,-0.413415806473677,-0.0736443000567359,0.00497275358660905
PLA2G15,Phospholipase A2 group XV,Health and medical history,X29153.Pain or discomfort today,35936,0.359211439421201,0.0793744666831937,0.203637484722142,0.514785394120261,6.1194511953434e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X29154.Anxiety or depression today,35936,0.2613584431952,0.105427852535787,0.0547198522250577,0.467997034165342,0.0131964638641821
PLA2G15,Phospholipase A2 group XV,Mental health,X29166.Frequency of confiding in someone close,35761,-0.171200811090236,0.0791649925610649,-0.326364196509924,-0.0160374256705491,0.0306063380804165
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35919,0.0202526528765853,0.00696762625764723,0.00659610541159676,0.0339092003415739,0.00366384075153101
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35919,-0.0337994848176506,0.00719942536822703,-0.0479103585393756,-0.0196886110959256,2.71795027029837e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35919,0.000985897631950308,0.00766130521099825,-0.0140302605816063,0.0160020558455069,0.897610175238754
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35919,0.00766676820507799,0.0106321357718968,-0.0131722179078398,0.0285057543179958,0.470874778542566
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35919,-0.011975860199076,0.0212646271201756,-0.0536545293546202,0.0297028089564681,0.57332805139436
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35919,-0.013297324860414,0.00778502037949041,-0.0285559648042152,0.00196131508338716,0.0876665910982108
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35914,-0.00378037968732409,0.00818034306398395,-0.0198138520927326,0.0122530927180844,0.644002040981217
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35914,-0.0218101312406893,0.0128266166399029,-0.0469502998548991,0.00333003737352042,0.0891018552413907
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35914,0.00902461698216736,0.0147232783664478,-0.0198330086160703,0.037882242580405,0.539929199858026
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35914,0.01424883164984,0.0180154954443025,-0.0210615394209929,0.0495592027206729,0.429015804010948
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35914,-0.000362420769933696,0.0295594595471203,-0.0582989614822894,0.057574119942422,0.99021792645078
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35914,0.0194569021022931,0.0119183799229827,-0.00390312254675308,0.0428169267513392,0.102614651452638
PLA2G15,Phospholipase A2 group XV,Mental health,X29171.Frequency of feeling 'in tune' with people,35738,-0.0915225094554506,0.0962524238264473,-0.280177260155287,0.097132241244386,0.341708018496355
PLA2G15,Phospholipase A2 group XV,Mental health,X29172.Freuency of feeling that lacks companionship,35872,0.128359674221508,0.0901271161749292,-0.0482894734813534,0.305008821924369,0.15442945883257
PLA2G15,Phospholipase A2 group XV,Mental health,X29173.Frequency of feeling left out,35845,0.184670685038733,0.093748014384029,0.000924576846035974,0.36841679323143,0.0488921839120861
PLA2G15,Phospholipase A2 group XV,Mental health,X29174.Frequency of feeling isolated from others,35878,0.188975298314095,0.0960728216635783,0.000672567853481659,0.377278028774709,0.0492210761690776
PLA2G15,Phospholipase A2 group XV,Mental health,X29175.Tendency to bounce back quickly after hard times,35929,-0.190357932818208,0.0776311087802843,-0.342514906027565,-0.0382009596088509,0.0142263538334326
PLA2G15,Phospholipase A2 group XV,Mental health,X29176.Ability to make it through stressful events,35929,0.112095656253569,0.0752645836777062,-0.0354229277547347,0.259614240261873,0.136437055343537
PLA2G15,Phospholipase A2 group XV,Mental health,X29177.Quick recovery from stressful events,35929,-0.12597083986323,0.07745332731559,-0.277779361401786,0.0258376816753268,0.103905545881786
PLA2G15,Phospholipase A2 group XV,Mental health,X29178.Hard to snap back when something bad happens,35929,0.0896800225609291,0.0760691079220311,-0.0594154289662519,0.23877547408811,0.238465022738169
PLA2G15,Phospholipase A2 group XV,Mental health,X29179.Comes through difficult times with little trouble,35929,-0.0763872682341036,0.0775472132286321,-0.228379806162223,0.0756052696940153,0.324635931857665
PLA2G15,Phospholipase A2 group XV,Mental health,X29180.Tendency to take a long time to get over setbacks,35929,0.0529098422895016,0.0763401655257946,-0.0967168821410559,0.202536566720059,0.488281315772735
PLA2G15,Phospholipase A2 group XV,Mental health,X29181.General happiness,35890,0.173917976181477,0.0788426249017528,0.0193864313740415,0.328449520988912,0.0274229632667401
PLA2G15,Phospholipase A2 group XV,Mental health,X29182.Belief that own life is meaningful,35791,-0.104793067573577,0.0797743183149937,-0.261150731470965,0.0515645963238106,0.189016346164059
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34850,-0.058846629805223,0.0751390492722848,-0.206119166378901,0.0884259067684551,0.433557120238533
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2946.Father's age,33545,-0.0149642328034902,0.00639483026569706,-0.0274981001242564,-0.00243036548272391,0.0193206409720778
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2966.Age high blood pressure diagnosed,35518,-0.0155465316808494,0.00523275247664224,-0.0258027265350682,-0.00529033682663061,0.00297847989748487
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30000.White blood cell (leukocyte) count,51649,0.0174550783939994,0.00214401472323119,0.0132528095364663,0.0216573472515325,4.10671007563602e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51650,0.00522398000553463,0.00230217989139762,0.000711707418395298,0.00973625259267396,0.0232687095965728
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30020.Haemoglobin concentration,51650,0.0224015553567736,0.0024221495177841,0.0176541423019167,0.0271489684116304,2.46582727017785e-20
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30030.Haematocrit percentage,51650,0.0180265509130341,0.00237743184840085,0.0133667844901685,0.0226863173358998,3.52116921930331e-14
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30040.Mean corpuscular volume,51650,0.0158155252614175,0.00212186348113497,0.011656672838393,0.0199743776844421,9.40250505630163e-14
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51650,0.0180760472849566,0.0021295633328437,0.013902103152583,0.0222499914173303,2.22436016211306e-17
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51650,0.00601135988211304,0.00207461406419228,0.00194511631629617,0.0100776034479299,0.00376408113161727
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51650,0.0253843488039681,0.00216629237227262,0.0211384157543138,0.0296302818536224,1.26919929671434e-31
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30080.Platelet count,51650,0.0132975045770501,0.0021196401152135,0.00914300995123168,0.0174519992028686,3.59360761397884e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30090.Platelet crit,51650,0.0104005975866784,0.00215752528131019,0.00617184803531042,0.0146293471380463,1.44028233274682e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51650,-0.0100263821751063,0.00200639731459453,-0.0139589209117116,-0.00609384343850101,5.85923989845531e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30110.Platelet distribution width,51650,0.0110718760431518,0.0020607074344334,0.00703288947166231,0.0151108626146413,7.82523003165173e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30120.Lymphocyte count,51612,0.00324964147924436,0.00208352842393215,-0.000834074231662653,0.00733335719015137,0.11884883337911
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30130.Monocyte count,51612,0.0297722268974708,0.00207886547045581,0.0256976505753774,0.0338468032195642,2.54542171474432e-46
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30140.Neutrophill count,51612,0.012697855255107,0.00211927775883585,0.00854407084778878,0.0168516396624253,2.1088123959272e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30150.Eosinophill count,51612,0.00692978658280176,0.00201997502538171,0.0029706355330536,0.0108889376325499,0.000603238658538292
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30160.Basophill count,51612,0.136129789910815,0.0444506925407292,0.0490064325309862,0.223253147290645,0.00219757345789975
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30170.Nucleated red blood cell count,51612,0.319280479429162,0.217350975929045,-0.106727433391767,0.745288392250091,0.141856572918512
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30180.Lymphocyte percentage,51613,-0.0102345998812066,0.00205869146518743,-0.014269635152974,-0.00619956460943923,6.69452065374963e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30190.Monocyte percentage,51613,0.0205759261824605,0.00206094920962693,0.0165364657315917,0.0246153866333293,2.00455120895428e-23
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30200.Neutrophill percentage,51613,0.000677671107798986,0.00203056669300196,-0.00330223961048486,0.00465758182608283,0.738582601985169
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30210.Eosinophill percentage,51613,0.00157743369883612,0.0020009170397769,-0.00234436369912661,0.00549923109679885,0.430496987375047
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30220.Basophill percentage,51613,0.00208566162451079,0.00208866940179873,-0.00200813040301472,0.00617945365203631,0.318018406216973
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30230.Nucleated red blood cell percentage,51611,0.321140854432144,0.218211621434684,-0.106553923579836,0.748835632444124,0.141117055381846
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30240.Reticulocyte percentage,51263,0.0365690139633586,0.00219269560207538,0.0322713305832909,0.0408666973434264,4.47006600046298e-62
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30250.Reticulocyte count,51263,0.0372382975809085,0.00221205468646062,0.0329026703954457,0.0415739247663713,3.31633863625512e-63
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30260.Mean reticulocyte volume,51263,0.0187217463243476,0.00208347774492374,0.0146381299442971,0.0228053627043982,2.76415459392562e-19
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30270.Mean sphered cell volume,51263,0.016590944695968,0.00209588628724008,0.0124830075729774,0.0206988818189586,2.56551623946462e-15
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30280.Immature reticulocyte fraction,51263,0.0256452484094205,0.00216569354446579,0.0214004890622676,0.0298900077565735,2.96180571226071e-32
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51263,0.0395854036914954,0.00222116394092088,0.0352319223672905,0.0439388850157003,1.44879622211733e-70
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30300.High light scatter reticulocyte count,51263,0.040139921476661,0.00222954836076443,0.0357700066895628,0.0445098362637593,5.79382707666627e-72
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30500.Microalbumin in urine,37051,0.0281648143210395,0.00339652366630734,0.0215076279350771,0.0348220007070019,1.28230269274495e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51706,-0.00297008577675557,0.00225173128868687,-0.00738347910258184,0.00144330754907069,0.18717443297497
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30520.Potassium in urine,51659,-0.00428923847669826,0.00210419879263602,-0.00841346811026485,-0.000165008843131665,0.0415194473221426
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30530.Sodium in urine,51672,-0.00521604553386101,0.00217060662214531,-0.00947043451326582,-0.000961656554456191,0.0162674372750958
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30600.Albumin,49489,-0.00266444784297621,0.00222218091121204,-0.0070199224289518,0.00169102674299938,0.23053228504277
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30610.Alkaline phosphatase,51225,0.0393896610939934,0.00217479457498292,0.0351270637270269,0.04365225846096,8.39602215043665e-73
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30620.Alanine aminotransferase,51210,0.0665832486517695,0.00232604314509815,0.0620242040873771,0.0711422932161618,4.68661958829487e-177
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30630.Apolipoprotein A,49427,-0.0097377919309508,0.0024028354355068,-0.0144473493845441,-0.00502823447735746,5.08298491928913e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30640.Apolipoprotein B,51064,-0.00171497636834524,0.0020510922419479,-0.00573511716256313,0.00230516442587265,0.403091595550298
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30650.Aspartate aminotransferase,51143,0.0716112461347253,0.00212971611709281,0.0674370025452234,0.0757854897242272,6.78414128133346e-242
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30660.Direct bilirubin,49671,0.0146525032699336,0.00223395942070547,0.0102739428053508,0.0190310637345163,5.54328152199486e-11
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30670.Urea,51207,-0.0569450331511803,0.0021149722654486,-0.0610903787914595,-0.052799687510901,3.39239133611075e-157
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30680.Calcium,49480,0.00819404598096506,0.0022018539438179,0.00387841225108197,0.0125096797108481,0.000198617134887528
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30690.Cholesterol,51228,-0.00438757350660752,0.00206740812051852,-0.00843969342282383,-0.000335453590391221,0.0338269066967833
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30700.Creatinine,51215,-0.0330040433992465,0.00266616163230787,-0.0382297201985699,-0.0277783665999231,4.4191810952102e-35
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30710.C-reactive protein,51148,0.0426062252621294,0.00227113253628895,0.0381548054910031,0.0470576450332558,6.3041154468841e-78
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30720.Cystatin C,51233,0.0547327623825778,0.00244618627247377,0.0499382372885292,0.0595272874766264,1.07349492248826e-109
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30730.Gamma glutamyltransferase,51211,0.079653398207334,0.00243789617846189,0.0748751216975487,0.0844316747171193,7.81621323175121e-229
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30740.Glucose,49455,0.0252181612715514,0.0020943065707842,0.0211133203928144,0.0293230021502884,2.77962263408578e-33
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51115,0.0175904865584534,0.00211293529147661,0.0134491333871592,0.0217318397297476,8.89681549658936e-17
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30760.HDL cholesterol,49467,-0.0249426533223016,0.00248412459669394,-0.0298115375318217,-0.0200737691127814,1.14116586139928e-23
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30770.IGF-1,51120,-0.0609841240986811,0.0021553051902331,-0.0652085222715379,-0.0567597259258242,4.24504353667506e-173
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30780.LDL direct,51174,-0.00706708703934844,0.00206345502617121,-0.011111458890644,-0.00302271518805287,0.000616163384709391
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30790.Lipoprotein A,46644,-0.0160461580046224,0.00225692579081359,-0.020469732554617,-0.0116225834546278,1.20609588622134e-12
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30810.Phosphate,49427,-0.0121023642955165,0.00214871927958161,-0.0163138540834965,-0.00789087450753657,1.80051753033528e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30830.SHBG,49331,0.0444388233344231,0.00284601974322766,0.0388606246376968,0.0500170220311493,1.19038143686888e-54
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30840.Total bilirubin,51128,0.00351185622798291,0.00225517808854641,-0.000908292825568061,0.00793200528153388,0.119427277635403
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30850.Testosterone,50992,0.0330581249240224,0.00353875550347307,0.0261221641372152,0.0399940857108296,1.03353228587794e-20
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30860.Total protein,49455,0.0403079318724751,0.00216358057171168,0.0360673139519202,0.04454854979303,7.69078889257618e-77
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30870.Triglycerides,51199,0.0281818313355141,0.00216031059616878,0.0239476225670233,0.0324160401040049,9.335425344457e-39
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30880.Urate,51196,0.00136292227855055,0.00259436579307381,-0.00372203467587412,0.00644787923297521,0.599352504957132
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30890.Vitamin D,50540,-0.0332777603377946,0.00232278989642239,-0.0378304285347824,-0.0287250921408067,2.4149645015806e-46
PLA2G15,Phospholipase A2 group XV,Physical measures,X3137.Number of measurements made,49918,-0.00756864556197824,0.0533853941020806,-0.112204018002056,0.0970667268780997,0.887260087747514
PLA2G15,Phospholipase A2 group XV,Physical measures,X3143.Ankle spacing width,42012,0.0118090204781194,0.00376374104943462,0.00443208802122759,0.0191859529350113,0.00170720367402088
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42011,-0.0130627906398811,0.00273705012680201,-0.0184274088884131,-0.00769817239134919,1.83799786019215e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X3146.Speed of sound through heel,42012,-0.0168463320201756,0.00264461295440671,-0.0220297734108127,-0.0116628906295384,1.95128299145352e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42012,-0.0160718406257778,0.00266942622093104,-0.0213039160188026,-0.0108397652327529,1.78189384212862e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X3148.Heel bone mineral density (BMD),41993,-0.0171106932140405,0.00268177955392527,-0.022366981139734,-0.011854405288347,1.82496740196731e-10
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3526.Mother's age at death,42796,-0.00843164531387249,0.00271113415805586,-0.013745468263662,-0.00311782236408301,0.00187453533937715
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32983,0.00750553834976368,0.00472195808679952,-0.00174949950036338,0.0167605761998907,0.112020347597924
PLA2G15,Phospholipase A2 group XV,Physical measures,X4100.Ankle spacing width (left),36224,0.010831487668266,0.00504835616833316,0.000936709578333004,0.020726265758199,0.0319405889746713
PLA2G15,Phospholipase A2 group XV,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36222,-0.0194888628448871,0.00362957387363205,-0.0266028276372059,-0.0123748980525683,8.12998171553009e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4103.Speed of sound through heel (left),36224,-0.0233750313306645,0.00347045454034786,-0.0301771222297463,-0.0165729404315827,1.75315259762226e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36224,-0.0226761275946754,0.00351944831546542,-0.0295742462929876,-0.0157780088963631,1.24177976197886e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4105.Heel bone mineral density (BMD) (left),36213,-0.0219344784668668,0.00353946543736258,-0.0288718307240974,-0.0149971262096361,6.05014546629183e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36224,-0.0226756236401775,0.0035196681588166,-0.0295741732314581,-0.015777074048897,1.24622944665151e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,X4119.Ankle spacing width (right),36213,0.0105940421384188,0.00494158037571546,0.000908544602016531,0.0202795396748211,0.0320759197626177
PLA2G15,Phospholipase A2 group XV,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36212,-0.0191550183346716,0.00366110497670336,-0.0263307840890102,-0.011979252580333,1.72128268637358e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X4122.Speed of sound through heel (right),36213,-0.0218630098942069,0.00347223688227813,-0.0286685941834721,-0.0150574256049418,3.2129352684605e-10
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36213,-0.0212924844101168,0.00353219364576079,-0.028215583955808,-0.0143693848644257,1.73614165602977e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X4124.Heel bone mineral density (BMD) (right),36201,-0.0205520105644184,0.00355274491270509,-0.0275153905933203,-0.0135886305355164,7.54663849041196e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36213,-0.0212924375077777,0.00353219151293115,-0.0282155328731228,-0.0143693421424326,1.73624468186366e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X4194.Pulse rate,36602,0.0443492737211696,0.00325697923946734,0.0379655944118136,0.0507329530305256,9.28337804389226e-42
PLA2G15,Phospholipase A2 group XV,Physical measures,X4195.Pulse wave reflection index,36602,-0.0169808897193995,0.00345121117866299,-0.0237452636295789,-0.01021651580922,8.81498393461087e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X4196.Pulse wave peak to peak time,36595,-0.0182243162858023,0.00379467401863998,-0.0256618773623367,-0.0107867552092679,1.59463382518346e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4198.Position of the pulse wave peak,36602,0.0335672550716688,0.00410387211606159,0.0255236657241881,0.0416108444191496,3.29150614390531e-16
PLA2G15,Phospholipase A2 group XV,Physical measures,X4199.Position of pulse wave notch,36602,0.0327108270672059,0.00332204994444218,0.0261996091760992,0.0392220449583126,9.54722199069172e-23
PLA2G15,Phospholipase A2 group XV,Physical measures,X4200.Position of the shoulder on the pulse waveform,36602,0.0372143258312293,0.00417242569512315,0.029036371468788,0.0453922801936707,5.74880312383281e-19
PLA2G15,Phospholipase A2 group XV,Physical measures,X4269.Number of triplets attempted (left),36379,-0.246048955203372,0.208425878437324,-0.654563676940528,0.162465766533783,0.237833363947729
PLA2G15,Phospholipase A2 group XV,Physical measures,X4270.Volume level set by participant (left),36289,0.131394771246023,0.0688611859966237,-0.00357315330735969,0.266362695799405,0.0564141211420422
PLA2G15,Phospholipase A2 group XV,Physical measures,X4276.Number of triplets attempted (right),36385,-0.238294616228854,0.206517629739032,-0.643069170517357,0.166479938059649,0.248588715311328
PLA2G15,Phospholipase A2 group XV,Physical measures,X4277.Volume level set by participant (right),36296,0.136864375624784,0.0685952346959563,0.00241771562071005,0.271311035628859,0.0460512530448395
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4288.Time to answer,36569,-0.00174159643919014,0.00391569424828125,-0.00941635716582138,0.0059331642874411,0.656495636362622
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4290.Duration screen displayed,36569,0.0113744362626834,0.00367120029343021,0.00417888368756023,0.0185699888378067,0.00195319450588064
PLA2G15,Phospholipase A2 group XV,Physical measures,X46.Hand grip strength (left),52256,-0.0275962664374147,0.00273302921318343,-0.0329530036952542,-0.0222395291795751,6.34815149837861e-24
PLA2G15,Phospholipase A2 group XV,Physical measures,X47.Hand grip strength (right),52255,-0.0254546534737792,0.0026921118306738,-0.0307311926618999,-0.0201781142856586,3.5116037206545e-21
PLA2G15,Phospholipase A2 group XV,Physical measures,X48.Waist circumference,52313,0.0561987334001698,0.00511173548497155,0.0461797318496256,0.066217734950714,4.77058504233703e-28
PLA2G15,Phospholipase A2 group XV,Health and medical history,X4803.Tinnitus,36423,-0.0364329039052058,0.0779579586866023,-0.189230502930946,0.116364695120535,0.640269375131471
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4825.Noisy workplace,36498,0.197341781056241,0.0739520746115014,0.0523957148176981,0.342287847294784,0.00763444099390733
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4836.Loud music exposure frequency,36450,0.0776408314050882,0.0992751939894257,-0.116938548814186,0.272220211624362,0.43419300299215
PLA2G15,Phospholipase A2 group XV,Physical measures,X49.Hip circumference,52307,-0.0130356899596402,0.00377943100360282,-0.0204433747267017,-0.00562800519257869,0.000563405904834021
PLA2G15,Phospholipase A2 group XV,Physical measures,X50.Standing height,52266,-0.00164369212148931,0.00286120837305375,-0.00725166053267465,0.00396427628969604,0.565652005689236
PLA2G15,Phospholipase A2 group XV,Health and medical history,X5057.Number of older siblings,35553,0.100603618148272,0.073737985163229,-0.0439228327716568,0.245130069068201,0.172505020262128
PLA2G15,Phospholipase A2 group XV,Physical measures,X51.Seated height,52161,-0.00134730441532388,0.00249213900192302,-0.006231896859093,0.00353728802844524,0.588773470592741
PLA2G15,Phospholipase A2 group XV,Eye measures,X5181.Ever had eye surgery,33964,0.216558495701064,0.164496187475861,-0.105854031751624,0.538971023153752,0.188064045905294
PLA2G15,Phospholipase A2 group XV,Eye measures,X5186.Duration visual-acuity screen displayed (right),33953,0.00180429751099637,0.0042532799575781,-0.00653213120585671,0.0101407262278495,0.671427380185933
PLA2G15,Phospholipase A2 group XV,Eye measures,X5188.Duration visual-acuity screen displayed (left),33949,0.00812972311727059,0.00437825060299925,-0.000451648064607936,0.0167110942991491,0.0633884578972647
PLA2G15,Phospholipase A2 group XV,Eye measures,X5190.Duration at which refractometer first shown (right),33897,0.00520764829086191,0.00439549980331733,-0.00340753132364006,0.0138228279053639,0.236162271520223
PLA2G15,Phospholipase A2 group XV,Eye measures,X5193.Duration at which refractometer first shown (left),33893,0.00429459595304976,0.00441734187707778,-0.00436339412602269,0.0129525860321222,0.330989160628883
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5199.logMAR, initial (right)",33931,0.0852303818615604,0.0860026488088774,-0.0833348098038394,0.25379557352696,0.321720591597441
PLA2G15,Phospholipase A2 group XV,Eye measures,X5200.Final number of letters displayed (right),33931,-0.0761586243598073,0.531229710381059,-1.11736885670668,0.965051607987067,0.886009013326497
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5201.logMAR, final (right)",33870,0.00702830922327371,0.00422330488258096,-0.00124936834658497,0.0153059867931324,0.0961373477518766
PLA2G15,Phospholipase A2 group XV,Eye measures,X5202.Number of rounds to result (right),33931,-0.0572883245160057,0.0813557712631281,-0.216745636191737,0.102168987159725,0.481357494529135
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5206.logMAR, initial (left)",33926,0.117974769659731,0.0862855209385345,-0.051144851379797,0.287094390699258,0.171601431380381
PLA2G15,Phospholipase A2 group XV,Eye measures,X5207.Final number of letters displayed (left),33926,-0.381927740067678,0.491304903553037,-1.34488535103163,0.581029870896274,0.436972588852877
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5208.logMAR, final (left)",33879,0.00635062206604394,0.00426291793246765,-0.00200469708159266,0.0147059412136805,0.136353420073469
PLA2G15,Phospholipase A2 group XV,Eye measures,X5209.Number of rounds to result (left),33922,-0.0107330909109224,0.0812189567624269,-0.169922246165279,0.148456064343434,0.894870598111036
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33726,0.00295569619859842,0.00422381086364916,-0.00532297309415393,0.0112343654913508,0.484102696567606
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33726,0.00774966235856806,0.00415015640362241,-0.000384644192531866,0.015883968909668,0.0619142044848048
PLA2G15,Phospholipase A2 group XV,Eye measures,X5256.Corneal hysteresis (right),33726,0.00628283045012477,0.00429807161461446,-0.00214138991451958,0.0147070508147691,0.143863103305244
PLA2G15,Phospholipase A2 group XV,Eye measures,X5257.Corneal resistance factor (right),33726,0.00924109374817753,0.00423698345348853,0.00093660617934002,0.0175455813170151,0.0292246501589446
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33700,-0.00299803619534993,0.00425518599925518,-0.0113382007538901,0.00534212836319023,0.481115926418164
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33700,0.00556050592270132,0.00420586246199392,-0.00268298450280676,0.0138039963482094,0.186199278622835
PLA2G15,Phospholipase A2 group XV,Eye measures,X5264.Corneal hysteresis (left),33700,0.0132531722454004,0.00424267364476727,0.00493753190165655,0.0215688125891443,0.00179545986461035
PLA2G15,Phospholipase A2 group XV,Eye measures,X5265.Corneal resistance factor (left),33700,0.0141270983746961,0.0042125963142844,0.00587040959869866,0.0223837871506935,0.000803673849092344
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34634,-0.0859438949554582,0.367681256238366,-0.806599157182656,0.634711367271739,0.815190375021111
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52244,0.0333284268563224,0.0111419874350304,0.0114901314836627,0.055166722228982,0.00278127805256341
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52244,0.0308098931344367,0.0129529573597306,0.00542209670936475,0.0561976895595087,0.0173864570646605
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52244,-0.00769799416617984,0.0320436263644072,-0.070503501840418,0.0551075135080583,0.810150319794322
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52244,-0.0059130145846089,0.00508739235009349,-0.0158843035907921,0.00405827442157434,0.245130270472786
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52244,-0.00719934170523693,0.00471825716227304,-0.0164471257432921,0.00204844233281822,0.127061180826834
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38964,-0.0275763736421419,0.00617786728754485,-0.0396849935257298,-0.015467753758554,8.13932490931608e-06
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38964,0.0100563474907742,0.0191798388036853,-0.027536136564449,0.0476488315459974,0.600068129470206
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38964,-0.00288888731734848,0.0119053726144433,-0.0262234176416574,0.0204456430069604,0.80827817977174
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38964,0.0166530052286601,0.00718426972885848,0.00257183656009752,0.0307341738972227,0.020469689789035
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52318,0.0173923643125859,0.0107936351808699,-0.00376316064191911,0.0385478892670909,0.10711595210057
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52318,0.0173923643125859,0.0107936351808699,-0.00376316064191911,0.0385478892670909,0.10711595210057
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52318,-0.000775719899934685,0.00783393691496559,-0.0161302362532672,0.0145787964533979,0.921122875913615
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52318,-0.0273478098778476,0.0137776499943496,-0.0543520038667729,-0.000343615888922351,0.0471626376336799
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52318,0.00310783471904785,0.0327907254306612,-0.0611619871250482,0.0673776565631439,0.924492075077298
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52318,0.0374388379977732,0.0230527465824583,-0.00774454530384517,0.0826222212993916,0.104378195631121
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52318,0.0772903618667916,0.0344054422671529,0.00985569502317193,0.144725028710411,0.0246838843366414
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52243,0.00168889375390525,0.00696633403114302,-0.0119651209471351,0.0153429084549456,0.808444045110606
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52243,0.0160703229431791,0.0123147363359302,-0.00806656027524405,0.0402072061616022,0.191916829348292
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52243,0.00684640266446498,0.0063793894887962,-0.00565720073357557,0.0193500060625055,0.283189400269045
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52243,0.0382098731553903,0.00941681980193427,0.0197529063435991,0.0566668399671814,4.97346121761658e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52243,0.0237034279424716,0.00952665711366652,0.00503117999968528,0.042375675885258,0.0128490162701281
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52243,0.0455872778968869,0.00536296335211084,0.0350758697267496,0.0560986860670241,1.9996093778477e-17
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37131,0.0106296727591504,0.0104282792145322,-0.00980975450133266,0.0310691000196334,0.308083654911375
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37131,0.0067122458199461,0.00996576052799692,-0.0128206448149279,0.0262451364548201,0.500627960998185
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37131,0.0294647361480504,0.01447385865956,0.00109597317531275,0.057833499120788,0.0418092274935625
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37131,0.00403671453602189,0.0107845142855923,-0.017100933463739,0.0251743625357828,0.708185548661149
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52194,0.0211087997914075,0.0188828010626364,-0.0159014902913599,0.0581190898741748,0.263627500661763
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52194,0.0177754141834511,0.0233518144476715,-0.0279941421339852,0.0635449705008873,0.446544892819047
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52194,-0.0104433401955626,0.0467265216617339,-0.102027322652561,0.0811406422614358,0.823148940905178
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52194,0.0132583895247888,0.0446730444104817,-0.0743007775197554,0.100817556569333,0.766631560785993
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52194,0.0163809809950393,0.0178422583550265,-0.0185898453808127,0.0513518073708913,0.358575794230546
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52194,0.0107956691561614,0.0209680275639272,-0.030301664869136,0.0518930031814588,0.606653328155448
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52194,0.00831405354742244,0.00883168212895511,-0.00899604342532958,0.0256241505201745,0.346514888640524
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35677,0.0243362985056455,0.0149569647007961,-0.00497935230791478,0.0536519493192059,0.103762917578479
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35677,0.061496859905408,0.0147615749637096,0.0325641729765372,0.0904295468342788,3.13664913735089e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35677,0.0249694373365093,0.0208226939442693,-0.0158430427942585,0.065781917467277,0.230511567491888
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35677,0.00654133333737365,0.00752771548071825,-0.00821298900483412,0.0212956556795814,0.384894867132059
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38833,-0.0109729555779487,0.00656655996129558,-0.023843413102088,0.00189750194619067,0.0947452213817698
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38833,-0.0147805755414766,0.00727143516856297,-0.02903258847186,-0.00052856261109319,0.042109589498651
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38833,0.0131204972806569,0.00643163448563153,0.000514493688819057,0.0257265008724946,0.0413765232705843
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38834,0.0136294558130421,0.0148884965244381,-0.0155519973748565,0.0428109090009407,0.359984704084025
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38834,0.0711543770044474,0.00891851856401822,0.0536740806189717,0.0886346733899231,1.64271738202182e-15
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38834,0.0442343135067863,0.0160585741768335,0.0127595081201927,0.0757091188933798,0.0058874856854302
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52243,-0.0153123912335697,0.013825314765992,-0.0424100081749139,0.0117852257077745,0.268062353487629
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52243,0.0220975993083883,0.0111409220483024,0.000261392093715566,0.043933806523061,0.0473273585259539
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52243,-0.00542822081723462,0.0221061388479854,-0.048756252959286,0.0378998113248167,0.806030683747831
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52243,-0.0324569310031294,0.0124743221196989,-0.0569066023577392,-0.00800725964851952,0.00927668414065263
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52243,-0.0252230959224057,0.0127219748775738,-0.0501581666824504,-0.000288025162360993,0.0474192142420733
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52243,0.0249390712762619,0.0153681341133735,-0.00518247158595018,0.0550606141384741,0.104650184200528
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52243,0.0106949808525945,0.00445929954220239,0.00195475374987778,0.0194352079553112,0.0164766210364383
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34203,0.0503864989498885,0.0112389068079967,0.0283582416062149,0.0724147562935621,7.49907064229721e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34203,0.0785079767361014,0.0134339671514633,0.0521774011192333,0.104838552352969,5.38375912678175e-09
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34203,-0.0515724177811502,0.00999647893017589,-0.071165516484295,-0.0319793190780055,2.56738642432989e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34203,-0.00506036367363271,0.00888950472302898,-0.0224837929307695,0.0123630655835041,0.569208311132781
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52352,0.0169455447376024,0.00543575604888833,0.00629146288178127,0.0275996265934235,0.00182658043998616
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52352,0.0386872664932455,0.0180095026213207,0.00338864135545688,0.0739858916310342,0.0317112464125652
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52352,0.00150699891866961,0.00477306307514618,-0.00784820470861691,0.0108622025459561,0.752210273419862
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52352,0.00733083694722856,0.00446471651381087,-0.00142000741984074,0.0160816813142979,0.100613806251717
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52352,0.0553912709313009,0.00754998957592506,0.0405932913624878,0.070189250500114,2.26111418821775e-13
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52352,0.0196871174783267,0.00680734795736962,0.00634471548188223,0.0330295194747711,0.00383097458800657
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52352,-0.00226674630924205,0.00481091040580634,-0.0116961307046225,0.00716263808613837,0.637525203286785
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52352,0.0666241291942029,0.015661860171782,0.0359268832575103,0.0973213751308956,2.10874295513169e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45166,-0.0502142994496779,0.00493916912927844,-0.0598950709430636,-0.0405335279562921,3.29364965799648e-24
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45166,0.0304297086474528,0.00486592658894017,0.0208924925331301,0.0399669247617756,4.10845812748245e-10
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45166,0.00736781494086632,0.00630328395394007,-0.00498662160885623,0.0197222514905889,0.242466731074424
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45167,-0.0347768154923085,0.00982968564671169,-0.0540429993598634,-0.0155106316247535,0.000404368286576816
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45167,-0.0139457326792804,0.00558050027353813,-0.0248835132154151,-0.00300795214314562,0.01246364066743
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52126,-0.0164174640132798,0.00511958710828048,-0.0264518547455095,-0.00638307328105005,0.0013440228285989
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52126,-0.0115813637023189,0.00402118808556092,-0.0194628923500183,-0.00369983505461949,0.00397926714569411
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52126,0.0125930366826838,0.00454174526273382,0.0036912159677255,0.0214948573976421,0.00556318283516346
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52126,-0.0427859182302197,0.00694743411360296,-0.0564028890928815,-0.0291689473675579,7.4616734680193e-10
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52149,-0.0262697051180931,0.00432958165023819,-0.0347556851525599,-0.0177837250836262,1.31905227875921e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52149,-0.0526413611700125,0.00603111993700913,-0.0644623562465504,-0.0408203660934746,2.75389958766634e-18
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52243,-0.0300444660167426,0.00441824139500448,-0.0387042191509514,-0.0213847128825338,1.07040579613791e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52243,-0.0307615644627849,0.00554224593046437,-0.0416243664864951,-0.0198987624390748,2.8810879182484e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52243,-0.0167820376448573,0.0119000097522464,-0.0401060567592602,0.00654198146954559,0.158477819326161
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52243,-0.0546590229445411,0.0108599189522979,-0.075944464091045,-0.0333735817980372,4.86159276986695e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52243,-0.0021527654603187,0.0131648746048526,-0.0279559196858298,0.0236503887651924,0.870107724081815
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52243,-0.0601960728231149,0.0135161868052722,-0.0866877989614484,-0.0337043466847814,8.48178842920441e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42012,-0.0160719092925174,0.00266943605776303,-0.0213040039657329,-0.0108398146193019,1.78185500507715e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X864.Number of days or week walked 10+ minutes,51878,-0.0159473065929134,0.0394888191341666,-0.0933453920958799,0.0614507789100531,0.686331448648533
PLA2G15,Phospholipase A2 group XV,Physical activities,X874.Duration of walks,49212,-0.00511886170130565,0.00206512064751996,-0.00916649817044476,-0.00107122523216653,0.01319331206545
PLA2G15,Phospholipase A2 group XV,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51278,-0.259411413413608,0.0383886326439103,-0.334653133395672,-0.184169693431544,1.43791416596047e-11
PLA2G15,Phospholipase A2 group XV,Physical activities,X894.Duration of moderate activity,46468,-0.0256005984133066,0.0463732601250896,-0.116492188258482,0.0652909914318691,0.580917453966204
PLA2G15,Phospholipase A2 group XV,Physical activities,X90087.No-wear time bias adjusted average acceleration,33344,-0.0232257549568498,0.00430845703964983,-0.0316703307545635,-0.0147811791591361,7.35709391668407e-08
PLA2G15,Phospholipase A2 group XV,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51196,-0.464780012314084,0.0396870854957357,-0.542566699885726,-0.386993324742442,1.37972952083861e-31
PLA2G15,Phospholipase A2 group XV,Physical activities,X914.Duration of vigorous activity,42115,-0.00898602400921016,0.00241558070206807,-0.0137205621852636,-0.00425148583315675,0.000200008399937361
